[
    {
        "page": 1,
        "text": "kear ta alexandria e = faculty of (ai latah poon medicine cists leek ede ss alexandria faculty of medicine"
    },
    {
        "page": 2,
        "text": ""
    },
    {
        "page": 3,
        "text": "table of contents section i. blood and immune system 3 chapter i- introduction and plasma functions 3 i-a. introduction 4 |-b. blood constituents 5 ko.plasma chapter il. red blood corpuscles 8 i-a. formed blood elements 9 ll-b. red cell structure 9 ll-c. the myeloid tissue 11 l-d. erythropoiesis 14 ll-e. role of red cells in oxygen transport 15 iil-f. hemoglobin 17 ll-g.lron turnover 30 chapter i. metabolism of vitamins vital to blood health 34 ill-a. folic acid: (folacin=pteroy! glutamic acid) 35 i1-b. cobalamin (vitamin b,.) 37 i-c. vitamin k 40 chapter iv. anemia and polycythemia 42 iv-a. anemias 43 iv-b. polycythemia 47 chapter v. blood groups and blood transfusion , 48 v-a. blood groups . 49 v-b. blood transfusion oo 51 chapter vi. platelets and hemostasis 54 vi-a. characteristics of mature platelets \" 55 vi-b. thrombopoiesis 57 vi-c. hemostasis 58 chapter vii. white blood cells 71 vil-a. granular leukocytes 72 vil-b. agranular leukocytes 76 vil-c. granulopoiesis 77 vil-d. lymphopoiesis 79 chapter vill. the immune system 81 vill-a. types of body defense mechanisms 82 vi-b. cells of the immune system 83 mil-c.immunoglobulins chapter ix. the lymphatic system 91 ix-a. the thymus 93 ix-b. lymph nodes 95 ix -c. the spleen 98 ix -d. the tonsils 100 practice questions 101 section il. carbohydrate metabousm . 104"
    },
    {
        "page": 4,
        "text": "list of figures figure 1. the formed blood element.cececececseseesessaeessanessesnseesegaes 5 figure 2. em picture of rbcs .oo.cssnesesneccecesececceusesenenssaanneess 10 figure 3. diagram of myeloid tissue occ cecseececessesececeuserasseneersenenans 12 figure 4. role of erythropoietin in erythropoiesis .0.00..ccec cece ecesesenseesesesesses 16 figure 5. structure of nemec 200.00. cseuecececcesensceseceesecseuececeececsrsursaneeueauausneevens 18 figure 6. structure of hemoglobin- simplified . cece c ceeseceaesaenessnesnesens 19 figure 7. hemogiodin. 00.00.00. cecescecessnsesseseceecsauuasscenessaecsseecseseeasueninenetensnees 19 figure 8. oxyhemoglobin vs reduced hemoglobin .ceeccecececsecesseteesteeseseetnens 20 figure 9. sickle cems 2.0.0. ceecescesececeensaesenuaessneeasaseessesauneccseccsseesenssners 21 figure 10. polymerization of deoxyhemoglobin s.. 0.0.0.0. c cceeseccecessesnesseuneesnees 22 figure 11. sickle cells are trapped in small blood vessels.cseeseseses 23 figure 12. reduction of met-hemoglobin by the nadh-cytochrome b5 methemo-globin fecuctase syslom .cssccsesesseceeseneeccssecesueecesessueascaueenuausasuucutessecuesseseessesenseess 24 figure 13. synthesis of 6-aminolevulinic aci 0.2. e ccecessessesesestscseseeses 25 figure 14. synthesis of porphobilinogen 0.0.0.0. cc cseceessescseecesesseecesecsnenteueens 26 figure 15. synthesis of uroporphyrinogen .csceeseceseceecennesenuessvseessnese 26 figure 16. synthesis of coproporphyrinogen.c.cssesesessesensusessneccsseescsseesenens 27 figure 17 (a) synthesis of hemoglobin 17 (b) catabolism of heme.:ce 28 figure 18. life cycle of red diog ceiis.cecsececcseseesessesuesessuueescesuesavsneaass 30 figure 19. iron adsorption 0. cece cec e e cece e eaeseesceaeseseessaseses 31 figure 20. folic acid (top) and tetrahydrofolate (right) .00 c cecceecessessessene 35 figure 21. sources and utilization of one-carbon substituted folates .0.0 ee 36 figure 22. vitamin b12. cc cscsesseesesesueccssecsseecesesseseresesnecersessesueesetescsaveseneess 37 figure 23. reactions catalyzed by cobalamin coenzymes in mammalian tissues. 39 figure 24, vitamin k. c cesscesessneescenseececseesecseseesensecesaueaesersuececsuueeucesuuesseneess 40 figure 25. vitamin k-dependent carboxylation of prothrombin precursor to prothrombin e ecn e ceaeceaneceuecaeaueeseaaescsaaescaessaaeessaneeseaceesaeseaeesseaeceseaeesseaeseeaeesseesesseesesasessuseesstessnsneseas 40 figure 26. the chelation of calcium ion by the y--carboxy glutamyl residue in clotting factor proteins. ec cecscssesessessecsseseescsuecsseccseesaesesueeceseecesessecesstesentesenstenses 41 figure 27. red cell appearance in different types of anemia .censenaes 44 figure 28. measurement of red cell indices o.oo cesecesesesseseserenstenstesenatens 45 figure 29. agglutinins and agglutinogens in the different blood types.ces 49 figure 30. the blood platelet 2.2.0.0. eceeceesntesenessasesaesecesesesesessaes 55 figure 31. thrombopoiesis 0.0.0.0. cececcennessenesessaeusaesessaesessesessaaees 57 figure 32. resting and activated platelets. .0.cscsesesesessescseanees 59 figure 33. fibrin clot entangling red blood cells (scanning electron microscope photo) 59 figure 34. the intrinsic pathway of blood clotting 2.00.2. ee eeccecesecentnessesutenssaes 62 figure 35. the extrinsic pathway of blood clotting ..0. e e eteenetenesenaes 63 figure 36. the final common pathway leading to fibrin formation .c e 64 figure 37. purplish spots in a patient with idiopathic thrombocytopenic purpura. 68 figure 38. bleeding into a knee joint as occurs in hemophilia.:.::ceteetes 69 figure 39. neutrophil . ec c e e een eeneaeseaesesaeeseaaeesnaeseaenessesneenenenee 73 figure 40. eosinophil 0.0.2. c cee ce cette eaaeceanessuaeseaeesesseaesenesenes 74 figure 41. basopnil .0 ec cece ceneneseseaeseneseseaenaeseaeeseeneesseneeseneetenes 75 figure 42. monocyte. 2. c enee e e e eeaneaaesesaaeeseaeeseaaeseeaessanenes 76 figure 43. lymphocyte 20.00. cece e e terrae e eeaaeseaaesaesaeeseessaaeessepessenaes 78 figure 44. formation and differentiation of lymphocytes. e enenenenes 80 figure 45. chemotaxis and diapedesis .0.0 c cece een e renee eters e ee eraeeseae senate 85 figure 46. electrophoretic pattern of serum proteins .0. cc c ee eect ee eaeteenetenees 86 figure 47. basic structure of igg molecules ..0.0. ec ce e e aeaaeaaeeaaeeaaeaaees 87 figure 48. structure of the immunogioduiin 0. ee ene eer e tener neat eteneanene 88 figure 49. structure of iqa.cec eect etree e tee eet nne eet taeseaeaaeseaengaaeneas 89 figure 50. structure of iqm o. eerie ee rirnertenneesennesenees 90 figure 51. the lymphatic system .0.cee teen e erence eect aecae een seseaaesnenaensaaes 92 figure 52. cells in the thymus. .0.0::ceececeaeceaeceaaeseaaesneaeneeaaes 93 figure 53. the blood-thymus barrier .0. c c een e een ee cent e e trite eres tenes nieenenesenenen 95 figure 54. structure of the lymph node. . cece ene etter tenner ene eter ete et enee erent ee tnaneeneneta 96 figure 55. circulation in the lymph node .cece eect e ennee eet eenesenesenesenaes 97 figure 56. the spleen .:eceecece e e ne etna e e tees tees tesco senesced eoeesonesneesesneeseneseneseniae 99 figure 57. the palatine tomsill . c cece e e e ee e ee teense e ee e ee sree eaenaeassegcnets 101"
    },
    {
        "page": 5,
        "text": "chapter i- introduction and plasma functions after studying this chapter the student should be able to: 1. identify the physical properties of blood including specific gravity, ph and viscosity 2. list blood cell types and identify components of plasma proteins 3. discuss the functions of plasma proteins 4. describe the role of plasma proteins in regulation of blood volume. about 60% of the adult human body is fluid, mainly a water solution of ions and other substances. although most of this fluid is inside the cells (intracellular fluid), about one third is in the spaces outside the cells (extracellular fluid). this extracellular fluid is in constant motion throughout the body. it is transported rapidly in the circulating blood and then mixed between the blood and the tissue fluids by diffusion through the capillary walls. this chapter discusses the properties of blood, with focus on plasma."
    },
    {
        "page": 6,
        "text": "chapter i. introduction and plasma functions i-a. introduction blood is a connective tissue fluid that circulates through the body to maintain a constant environment around the body cells. blood is the main transportation vehicle of the body; it carries o, and nutrients to the tissues and returns co, to the lung and other products of metabolism to the kidneys. it carries and distributes hormones and other agents that regulate cell functions. it functions also in regulation of body temperature, acid base equilibrium and water balance. blood plays a vital protective function against infection. furthermore, injury to blood vessels is followed by blood clotting which stops further loss of this vital fluid. thus blood helps to maintain homeostasis and to coordinate activities of various organs. blood is a highly complex fluid in which cellular elements are suspended. the fluid portion is the plasma, which forms 55% of blood volume (which averages around 5 litres). the cellular elements include red blood cells, white blood cells and platelets, and this form the remaining 45%. blood constitutes about 8% of body weight. physical properties of blood 1. colour arterial blood is bright red due to presence of oxyhemoglobin. venous blood is dark red (bluish) due to presence of reduced hemoglobin. 2. viscosity blood is 5 times more viscous than water. this high viscosity is due to presence of cells (mainly rbcs) and plasma proteins. blood viscosity decreases in cases of anemia and hypoproteinamia and increases in cases of polycythemia and dehydration. blood viscosity is essential for maintaining normal arterial blood pressure (abp) by preventing rapid flow of blood from arteries to veins. 3. ph the ph of arterial blood is 7.440.02. that of venous blood is 7.3840.02. 4. specific gravity specific gravity of whole blood is 1060. specific gravity of cells is 1090, while that of plasma is 1030."
    },
    {
        "page": 7,
        "text": "chapter i. introduction and plasma functions i-b. blood constituents a. blood plasma: it is the fluid component in which blood cells are suspended. b. formed blood elements (figure 1) - red blood corpuscles (rbcs) or erythrocytes. - white blood cells (wbcs) or leukocytes including the granular leukocytes (neutrophils, eosinophils and basophils) and the agranular leukocytes (lymphocytes and monocytes). - blood platelets. + a band neutrophil ry platelet >. lymphocyte %& ss basophil eosinophil segmented neutrophil monocyte = : figure 1. the formed blood elements plasma is a remarkable solution containing numerous ions, and inorganic and organic molecules that aid the transport of other substances. normal plasma volume is about 3 litres. constituents of plasma 1. water (90%) 2. inorganic constituents (1%) e.g. sodium, chloride, calcium, potassium go s"
    },
    {
        "page": 8,
        "text": "chapter i. introduction and plasma functions 3. organic constituents (9%). these include: a- plasma proteins (7%) b- nutrients & waste products (2%) plasma proteins their concentration ranges from 7-9 g/dl. plasma proteins include: albumin (~4.8 g/dl) globulins (a, b,y) (~2.7 g/dl) fibrinogen (~0.2 g/dl) prothrombin (~0.02 g/dl) sources of plasma proteins 1. albumin, fibrinogen, prothrombin and most of alpha and beta globulins are formed in the liver. 2. gamma globulins are manufactured in the lymphoid tissues. plasma proteins are continuously used by the tissues i.e. there is continuous turnover between proteins in the liver, plasma and tissues. they are dynamic and not static. functions of plasma proteins 1. protein metabolism plasma proteins are constantly used by the tissues for their protein metabolism (thus they are dynamic). 2. blood coagulation some of the plasma proteins (the clotting factors) are needed for blood coagulation. the most important of these are prothrombin and fibrinogen. 3. immunity antibodies (gamma globulins) protect the body against pathogenic organisms and their toxins. 4. transport of important substances plasma proteins function in the transport of hormones such as thyroid, adrenal and gonadal hormones from endocrine glands to target organs, thus preventing their rapid excretion through the kidney. they also serve as carries for metals including iron, as well as fatty acids, amino acids, enzymes, drugs and carbon dioxide."
    },
    {
        "page": 9,
        "text": "chapter i. introduction and plasma functions 5. regulation of blood volume plasma proteins (specially albumin) exert a colloid osmotic pressure of about 25 mmhg. as the capillary walls are relatively impermeable to plasma proteins, this osmotic force tends to pullwater into the blood, thus maintaining blood volume. 6. buffering action the plasma proteins are responsible for 15% of the buffering power of the blood, which helps keeping the ph of tissues almost constant. arterial blood has a ph of 7.40.02, while that of venous blood is 7.3840.02. proteins are present in the blood as weak acids and their salts (proteinic acid and sodium proteinate). 7. regulation of arterial blood pressure whole blood is five times and plasma is two times as viscous as water. blood viscosity is due to red blood cells and plasma proteins. blood viscosity is responsible partially for the peripheral resistance, which is the resistance that the blood meets during its passage through the peripheral narrow blood vessel. it prevents the rapid outflow of blood through the vessels, thus maintaining normal arterial blood pressure."
    },
    {
        "page": 10,
        "text": "chapter ii. red blood corpuscles after studying this chapter the student should be able to: . recognize the methods for examining and counting the blood elements. recognize the general and structural features of red blood corpuscles. correlate the structure to functional adaptation of red blood corpuscles. mention the types of bone marrow and describe the histological components of the myeloid tissue. 5. define hemopoiesis and name the different colony forming units involved in formation of the blood elements. 6. list and describe different stages of erythropoiesis. 7. describe the regulatory role of erythropoietin in erythropoiesis, and feedback mechanism. 8. discuss the nutritional factors required for erythropoiesis, and their sources 9. list the key hormones needed for normal erythropoiesis 10.describe globin structure and state the types of normal and abnormal hemoglobin. 11. describe heme structure and importance of the heme molecule 12. outline hemoglobin abnormalities that may occur in sickle cell disease, thalassemia and methemoglobinaemia in light of their causes. 13.describe biosynthesis of heme and discuss its regulation and abnormalities inc. porphyria. 14. integrate structural abnormalities of hemoglobin to deviation of its function from normal. 15. discuss importance of glycolysis and hexose monophosphate shunt for rbc metabolism. 16. describe the fate of rbcs and catabolism of hemoglobin 17. discuss the dynamics of iron absorption 18. list the proteins and carriers involved in iron transport and storage 19. illustrate how iron balance is maintained in the body 20. discuss iron metabolism pens red blood cells are the most abundant cells of the blood and are necessary for the delivery of oxygen to the tissues. this chapter discusses red cell structure, function and formation (hemopoiesis), and the role and metabolism of hemoglobin."
    },
    {
        "page": 11,
        "text": "chapter ii. red blood corpuscles | ii-a. formed blood elements preparation of blood for laboratory study 1-blood smear (blood film) to examine or count the formed blood elements, a blood smear must be prepared. stains used in blood smear e.g. giemsa's stain are designed to differentiate blood cells by their nuclei and cytoplasmic granules. 2-blood count itis the average number of a particular formed blood element per cubic millimeter blood. recently, blood count is done by an automated hemocytometer. accordingly, we can perform: - rbcs count. - total leukocytic count. - platelets count. - differential leukocytic count: it is the percentage of each type of leukocytes relative to the total number of wbcs. it is done by counting the different types of leukocytes in blood smear. this count can be of diagnostic significance as it is associated with certain disease states. histologically, blood is considered a specialized type of connective tissue. the plasma represents the abundant matrix while the formed blood elements represent the cells. however, blood lacks the fibrous component of connective tissue and its cells originate from the stem cells of the myeloid tissue present in red bone marrow. _it-b. structure of red blood corpuscles red blood cells or erythrocytes (erythrum = red, cytes = cells) are so called because they are responsible for the red color of blood due to their content of hemoglobin. the circulating rbcs are non-nucleated cells as they lack the nucleus. hence, they are rather called red blood corpuscles than true cells. average rbc count in normal males is 5-5.5 millions/mm3 blood, in normal females is 4.5-5 millions/mm3 blood."
    },
    {
        "page": 12,
        "text": "chapter ii. red blood corpuscles life span of rbcs it is about 100-120 days. old & deformed rbcs are recognized and phagocytosed by the macrophages in the spleen and liver. lm picture of rbcs in blood film shape: eosinophilic biconcave discs. diameter: ranges between 7.2-7.8um. almost the size of the smallest blood capillaries. nucleus: absent. cytoplasm: hemoglobin occupies about 33% of the corpuscular volume and is more concentrated at the periphery. em picture of rbcs (figure 2) transmission em scanning em figure 2. em picture of rbcs shape: membrane- bounded electron- dense biconcave discs. cell organelles: no nucleus and no typical organelles. rbc membrane it is covered from outside by prominent glycocalyx coat, which is responsible for the blood grouping. it is supported from inside by a well-developed cytoskeleton, which is responsible for the flexibility of rbcs. it is formed of a network of microfilaments (actin & spectrin), that are attached to the plasma membrane peripheral protein (ankyrin). st ff}"
    },
    {
        "page": 13,
        "text": "chapter ii. red blood corpuscles adaptation of rbcs structure to function the histological characteristics of rbcs are designed to increase the gaseous carriage capacity of these corpuscles. these include: 1- the biconcave discoid shape increases the surface area of the rbcs by 20-30% more than if they had a spherical shape. 2- the lack of a nucleus and organelles allows more space in the cytoplasm for carrying the maximal amount of hemoglobin. this hemoglobin has been synthesized earlier during the process of erythrocytes formation in the bone marrow. 3- the concentration of hemoglobin at the periphery more than in the center of the corpuscle facilitates its binding to oxygen and carbon dioxide gases. 4- the structure of the cytoskeleton helps the rbcs to be squeezed as they pass through the narrowest blood capillaries without being damaged. 5- the corpuscular membrane is selectively permeable to oxygen and carbon dioxide gases to enhance their diffusion rates during the gaseous exchange processes. ii-c. the myeloid tissue the myeloid tissue or the red bone marrow is the tissue responsible for formation of all formed blood elements in postnatal life. sites - the central bone marrow cavity in young long bones. - the marrow cavities between the bone trabeculae of cancellous bone. types of bone marrow 1- red bone marrow: active in hemopoiesis. 2- yellow bone marrow: inactive bone marrow in which the blood formation has stopped. its yellow color is attributed to the presence of a large number of fat cells in its stroma. it can revert to the red type in stress conditions as hemorrhage and anemia. s19"
    },
    {
        "page": 14,
        "text": "chapter ii. red blood corpuscles histological structure of myeloid tissue (figure 3) /-the stroma. it includes: - reticular fibers. they form a network supporting the myeloid cells and blood sinusoids. - stromal cells. they represent the fixed cell population of the marrow stroma. they include: e reticular stromal cells: their function is to produce the reticular fibers and secrete growth factors that stimulate the marrow stem cells. in yellow bone marrow, these cells are changed to adipocytes by accumulating large fat droplets. e macrophages: their function includes phagocytosis of aged rbcs as well as the malformed blood elements and storage of iron for further utilization in hemopoiesis. e some adipocytes: they represent one of the largest cells in bone marrow. eosinophil cell normoblasts myelocyte dividing myelocyte myelocyte figure 3. diagram of myeloid tissue"
    },
    {
        "page": 15,
        "text": "chapter it. red blood corpuscles /-the blood sinusoids they are wide, irregular vascular channels lined by fenestrated endothelial cells. m/l-the myeloid cells these cells represent the free cell population of the bone marrow. they include: 1- pluripotent hemopoietic stem cells (phscs): - they have great ability to mitotic division. - they are relatively small cells with faint basophilic cytoplasm and euchromatic nuclei. - when they divide, they give rise to daughter cells; half of which remains as a reserve of the hpscs population while the other half develops into the more differentiated multipotent hemopoietic stem cells (mhscs). 2- multipotent hemopoietic stem cells (mhscs): - they can undergo several cell divisions, giving rise to more differentiated cell colonies for each of the formed blood elements. - hence, there are 2 types of colony forming units (cfus); e colony forming unit- lymphocyte (cfu- ly): complete their maturation giving rise to lymphocytes. e colony forming unit- granulocyte, erythrocyte, monocyte, megakaryocyte (cfu- gemm): further differentiate into the unipotent progenitors giving rise to: i. cfu-erythrocyte (cfu-e), ii. cfu-megakaryocyte (cfu-meg), i. cfu-neutrophil (cfu-g), iv. cfu-eosinophil (cfu-eo), v. cfu-basophil (cfu-ba), vi. cfu-monocyte (cfu-m). - these cells are larger and show more basophilia in their cytoplasm as they contain abundant ribosomes that initiate the synthesis of the specific products of each blood element. a fo)"
    },
    {
        "page": 16,
        "text": "chapter ii. red blood corpuscles ii-d. erythropoiesis hemopoiesis (hematopoiesis) is the formation of balanced amounts of the different blood elements. the number of the daily formed blood elements must equalize the amount of the daily destroyed elements. hemopoiesis includes: erythropoiesis, thrombopoiesis, granulopoiesis, monopoiesis, and lymphopoiesis. erythropoiesis it is the formation of rbcs. the whole process for production of mature rbcs takes about 7 days. erythropoiesis involves the following stages: 1. phscs. 2. mhscs. 3. colony forming unit- erythrocytes (cfu-e). 4 . proerythroblasts: they are the first recognizable erythrocyte precursor. they are large cells with basophilic cytoplasm. 5. basophilic erythroblasts: at this stage hemoglobin synthesis is most active. the cytoplasm is strongly basophilic due to abundant polysomes. 6. polychromatophilic erythroblasts: hemoglobin is accumulating in large quantities in the cytoplasm, ribosomes are still abundant. accordingly, the cytoplasm shows eosinophilic areas alternating with basophilic spots. these cells represent the /ast stage in which the cells undergo repeated cell divisions. the coming phases involve morphological maturation of the erythroblasts. 7. orthochromatophilic erythroblasts (normoblasts): the synthesis of hemoglobin is completed and ribosomes are much reduced in number. the nucleus becomes small and condensed. it is gradually pushed towards the periphery, extruded from the cell to be phagocytosed by the bone marrow macrophages. 8. reticulocytes: they are non-nucleated immature rbcs. they differ from mature rbcs in that: - they are slightly larger. - their cytoplasm contains remnants of ribosomes and other organelles which, on staining with cresyl blue stain, form a reticulate pattern. - they represent about 1% of all rbcs in a normal blood film. an increase in this percentage indicates an accelerated rate of erythropoiesis e.g. to compensate for anemia or hemorrhage. 9. mature rbcs. 14"
    },
    {
        "page": 17,
        "text": "chapter ii. red blood corpuscles ii-e. role of red cells in oxygen transport red blood cells (erythrocytes) transport hemoglobin, which is the main carrier of o, in the circulation. in normal adults the red cells occupy about 45% of the volume of the blood; this percentage volume of red cells in relation to whole blood is the \"hematocrit value. combination of hemoglobin with oxygen the most important feature of the hemoglobin is its ability to combine loosely and reversibly with o,. hemoglobin binds o, to form oxyhemoglobin, o, is attached to the fe (ferrous iron) in the heme. the affinity of hemoglobin for o, is affected by changes in ph, temperature and concentration of certain substances in the red cells. if blood is exposed to various drugs and other oxidizing agents, the fe** in the hemoglobin molecule is converted to ferric iron (fe) forming methemoglobin which is uncapable of carrying o,. carbon monoxide reacts with hemoglobin to form carbon monoxyhemoglobin. hemoglobin affinity for co is much more than its affinity for o,,thus reducing the o,-carrying capacity of blood. factors affecting formation of red blood cells (erythropoiesis) the formation or regeneration of red blood cells is controlled by several factors that are essential for perfect red blood cells regeneration or erythropoiesis. 1. tissue oxygenation: role of erythropoietin any condition that causes the quantity of o, transported to the tissues to decrease ordinarily increases the rate of red cell formation. the principal factor that stimulates red blood cell production is a circulating glycoprotein hormone called erythropoietin. lack of o, (hypoxia) stimulates formation of erythropoietin. most of the erythropoietin (90%) is formed in the kidney; the rest is formed mainly in the liver. erythropoietin in turn enhances red blood cell production by the bone marrow until the hypoxia is relieved (figure 4). erythropoietin stimulates production of proerythoblasts from haemopoietic stem cells in the bone marrow.!n the absence of erythropoietin, few red blood cells are formed by the bone marrow. on the other hand, when o, transport to tissues rises above normal, the rate of erythropoietin formation decreases (negative feedback mechanism). 15"
    },
    {
        "page": 18,
        "text": "ghaphar redred g@loaducorpuscles stimulus: hypoxia due to decreased rbc count, decreased amount of hemoglobin, or decreased availability of oo increases q2 - carrying ability of blood reduces o2 levels in blood enhanced ih * kidney (and liver to a smaller erythropoiesis erythropoietin extent) releases erythropoietin increases om stimulates red rbc count bone marrow figure 4. role of erythropoietin in erythropoiesis 2. nutritional factors the cells of the bone marrow are among the most rapidly growing and reproducing cells of the body, thus they are greatly affected by the person's nutritional status. especially important for formation and maturation of red blood cells are proteins, iron, vitamins, copper and cobalt. a) proteins animal proteins that are present in liver, kidney and muscles are superior in production of hemoglobin (globin fraction) compared to plant-derived proteins. animal proteins contain the essential amino acids, which are neither stored nor formed in the body. b) iron sixty percent of the iron in the body is in hemoglobin (heme fraction),3 % in myoglobin,and the rest is mostly in ferrltin, which is present in enterocytes, hepatocytes and many other cells. iron is also a constituent of cytochrome enzymes needed for intra-cellular oxidation. c) vitamins the two vitamins, vitamin b12 and folic acid are required for formation of thymidine tri-phosphate, an essential building block of dna. thus they are 16"
    },
    {
        "page": 19,
        "text": "chapter ii. red blood corpuscles important for nuclear maturation and cell division of red cell precursors, and are called maturation factors. the other vitamins (including vitamin c) influence the general metabolism and growth of body tissues including the bone marrow i.e. they are not specific for red blood cells formation. d) copper and cobalt copper and cobalt act as catalysts in hemoglobin synthesis. 3. hormones hormones are required for erythropoiesis as they promote tissues metabolism in general. however, they are not specific except erythropoietin. thyroxine hormones are the most powerful stimulant of body metabolism and their deficiency for long time can cause anemia. male hormones (androgens) and growth hormones stimulate body metabolism and erythropoiesis. 4. liver a healthy liver is essential for normal red blood cell formation. the liver manufactures globin, stores iron, copper, vitamin b12 and folic acid, and a small fraction of erythropoietin. 5. bone marrow it is the factory in which red cells and most other blood cells are formed. destruction of bone marrow by irradiation, chemicals, drugs or bacterial toxins will lead to deficiency of all blood cells which is called \"aplastic anemia. ii-f. hemoglobin hemoglobin structure 1- heme it is an iron-porphyrin (figure 5) compound composed of: a. porphyrins: these are cyclic compounds derived from the porphin nucleus made of 4 pyrrole rings linked by 4 methenyl bridges (-ch=) labelled a , b ,y and 6. the porphyrins found in nature are compounds in which side chains are substituted for the hydrogen atoms in porphin nucleus. there are different types of porphyrins. only types | and i occur in nature: 17"
    },
    {
        "page": 20,
        "text": "chapter i. red blood corpuscles 1- type | isomer. the substituent groups attached to the 4 pyrrole rings are symmetrically arranged e.g.(ap.ap.ap.ap). 2- type ill isomer. the substituent groups attached to the 4th pyrrole ring are arranged in the reverse order, e.g.(ap, ap, ap, pa). the biologically important porphyrin in heme and cytochrome are type ill isomers. b. iron: it is present in ferrous state (fe**) and is linked to 4 nitrogen atoms of 4 pyrrole rings. also, there are 2 additional bonds called 5\" and 6\" coordination bonds. these two bonds are located on each side of the heme plane (perpendicular to the heme plane). the 5\" position is linked to nitrogen atom of imidazol ring of proximal histidine, while the 6\" position is bound to oxygen in hbo, and empty in deoxyhemoglobin (hb) (unoccupied). the 4 pyrrole rings are attached to side chains called methyl, vinyl, methyl, vinyl, methyl, propionyl, propiony|l, methyl. (m,v,m,v,m,p,p,m).. the transport of o, is based on a physical interaction between molecular o, and iron of heme to provide reversible association ch3 w ch=ch? pyrrote rings labeled jollslff,iv ch3 = methy! {m) methenyt bridges 0.85.5 ch = ch2=vinyt (v) ch2-ch2-cooh = propionate (p) figure 5. structure of heme 18"
    },
    {
        "page": 21,
        "text": "chapter ii. red blood corpuscles the above-mentioned structure of heme can be drawn in a simplified manner as follows (figure 6): proximal histidine f8 distal histidine e7 figure 6. structure of hemoglobin- simplified 2- globin (protein part or apoprotein) it is a simple protein (histone) which is characterized by its high content of histidine and lysine. it is composed of four polypeptide chains 2a and 28 chains. the a-chain contains 141 amino acids and b-chain contains 146 amino acids. each b-polypeptide chain is folded into 8 right handed a-helices termed a-h starting from nh,-terminal, while a-subunit is folded into 7a-helices. the ratio of heme to globin is 4:1. so each heme moiety is linked to one peptide chain. figure 7. hemoglobin the myoglobin-hemoglobin family of proteins has produced a way in which fe** can be bounded to the proteins so as to produce an o, binding site. hemoglobin protects the o, binding fe from irreversible oxidation by providing environments in which the first step of an oxidation reaction (the binding of oxygen) is permitted, but the final step (oxidation) is blocked. 19"
    },
    {
        "page": 22,
        "text": "chapter ii. red blood corpuscles proximal histidine f8 proximal histidine f8 | n \\ m v n m v m m o2 m m p v p v o02 p m p m n | oxyhemoglobin n reduced hemoglobin | | distal histidine e7 distal histidine 7 figure 8. oxyhemoglobin vs reduced hemoglobin types of normal hemoglobin 41. adult hemoglobin. there are 2 types hba71 and hba2. a) major adult hemoglobin: hb a, (a, b.) contains 2 alpha chains and 2 beta chains. this hemoglobin a, constitutes 95-97% of the total hemoglobin. b) minor adult hemoglobin: hb a, (a, 5.) contains 2 a-chains and 2 5-chains. hba, forms about 2-4% of total hemoglobin. in the 5-chains there is more than one aminoacid different than those in b-chain e.g. arginine residue at the position 16 instead of glycine which is normally present in beta chain. 2. glycosylated hemoglobin (hb a1c) it is a modified form of hemoglobin similar to hemoglobin a, but it contains glucose linked to amino group present on lysyl residues and at the nh, - terminal ends. the reaction is non-enzymatic and its rate depends on the concentration of glucose. it is present in normal value 5% of the total hemoglobin. this percentage is increased in prediabetic and diabetic patients up to 8-14%. thus, glycohemoglobin gives an idea about the blood glucose level during the last three months and is useful in the assessment of diabetic control. 3. fetal hemoglobin = hbf (a2y2) it is present normally in newborn and early fetal life. at age of 7 months 90 % of fetal hemoglobin is replaced by adult hemoglobin (hba1). - it consists of 2 alpha chains and 2 gamma chains. 20"
    },
    {
        "page": 23,
        "text": "chapter ii. red blood corpuscles - in gamma chain there is more than one aminoacid different from those in b-chain e.g. his,, residue is ser, - hbf has a great affinity for o, under physiological conditions, because y- chains do not bind 2,3 bpg well. bpg is responsible for lowering the o, affinity of hb and allowing hb to release o, at the typical po, of tissues. abnormal types of hemoglobin 1. sickle cell disease (hbs) the glutamic amino acid is replaced by valine amino acid at the position number 6 of beta chain, due to mutation in the structural gene (a, s,). @ sickle . cells ee ew i. blood cells ~~ @ @ figure 9. sickle cells pathogenesis the presence of valine (nonpolar amino acid) instead of glutamic (polar amino acid) at position 6 of b-chain will lead to formation of sticky patches on the surface of hemoglobins of both oxyhemoglobin s and deoxyhemoglobin s. however both the deoxyhemoglobin s and a_ contains a compliementary patches (grooves). when the blood is deoxygenated, the sticky patches of deoxyhemoglobin s bind to the complementary patches of deoxyhemoglobin s, leading to polymerization of deoxyhemoglobin s leading to formation of long fibrous precipitates leading to sickling of rbcs. effects of sickling of rbcs a- sickle shaped rbcs are fragile and easily hemolysed so anemia will occur (sickle cell anemia). b- sickle shaped rbcs are easily trapped in small blood vessels leading to thrombus formation and damage of organs like brain, bone spleen, etc. 21"
    },
    {
        "page": 24,
        "text": "chr pefr tedred bloodveor?p uscles joa! oxy hba deoxy hba oxy hbs deoxy hbs figure 10. polymerization of deoxyhemoglobin s. the dissociation of oxygen from hemoglobin s (hbs) unmasks a sticky patch (red triangle) on the surface of its b-subunits (green) that can adhere to a complementary site on the b-subunits of other molecules of deoxyhbs. polymerization to a fibrous polymer is interrupted deoxyhba, whose b-subunits (lavender) lack the sticky patch required for binding additional hbs subunits. diagnosis a- reticulocyte count between 10-20%. b- sickle-shaped rbcs by microscopic examination. c- electrophoresis. shows hbs, no hba. hbs moves slowly due to less negative charges on its molecules, so it appears in paper electrophoresis nearer to cathode than normal hemoglobin. 2. thalassemias these are hereditary hemolytic diseases in which the synthesis of either a- or b- globin chain is defective due to mutation affecting the regulatory gene. types a- a-thalassemias: characterized by decreased or absent synthesis of a- chains of hemoglobin with compensatory increase in synthesis of other chains. include 2 types: i. pure b-chain hbh: where there are 4 b-chains (hbh disease). ii. pure y-chain-hb barts where there are 4 y-chains b- b- thalassemias: synthesis of b-chains is decreased or absent, whereas synthesis of a-chains is normal and will combine with 6-chains giving excess of hba2 (0252) or it may combine with y-chains producing excess of hbf (a2y2). 22"
    },
    {
        "page": 25,
        "text": "chapter ii. red blood corpuscles the abnormal hemoglobin does not function as normal hemoglobin and has an abnormal o2 dissociation curve. diagnosis - anemia: called cooley's anemia or mediterranian sea anemia. - electrophoresis: shows hbf, hbh, hba2. @ normal red blood cells normal red blood cells(rbc) cross-section of rbc. rbcs flow freely within blood vessel normal hemoglobin @ abnormal, sickled, red blood cells (sickle cells) sickle cells blocking blood flow sticky sickle cells abnormal hemoglobin from strands that cause sickle shape figure 11. sickle cells are trapped in small blood vessels 23"
    },
    {
        "page": 26,
        "text": "chapter ii. red blood corpuscles 3- methemoglobinaemia this is oxidized hb, the fe? normally present in heme being replaced by fe*. the ability to react as an o, carrier is lost. the normal erythrocyte contains small amounts of met-hb, formed by spontaneous oxidation of hb. met-hb is normally reconverted to hb by reducing systems in the rbc, the most important of which is nadh- methemoglobin reductase. excess met-hb may be present in blood because of increased production or diminished ability to convert it back to hb. types and causes of methemoglobinemia 1-congenital methemoglobinemia a- hemoglobin m (hb-m): a congenital condition due to mutation in globin biosynthesis in which distal or proximal histidine is replaced by tyrosine so heme iron is stabilized in the ferric state. treatment with reducing agents as methylene blue is ineffective. the treatment is only conservative as blood transfusion. b- deficiency of nadh cytochrome b5 methemoglobin reductase system: this is required for reducing heme fe3+ back to the fe2+ state. this system consists of nadh (generated by glycolysis), a flavoprotein named cytochrome b5 reductase (also known as met hb reductase),and cytochrome b5. met hb reductase system cyt bs cyt bo (reduced) (oxidized) na nadh +h* figure 12. reduction of met-hemoglobin by the nadh-cytochrome b5 methemoglobin reductase system treatment with reducing agents is effective in converting met hb back to hb in those patients. 24"
    },
    {
        "page": 27,
        "text": "chapter ii. red blood corpuscles 2- acquired (toxic) methemoglobinemea usually arises following the ingestion of large amounts of drugs e.g. phenacetin or the sulphonamides, excess of nitrites or certain oxidizing agents present in the diet may also cause it. treatment with injection of reducing agents like vitamin c or glucose or methylene blue is effective in reversing acquired methemoglobinemea. diagnosis of methemoglobinemia 1.cyanosis. 2. examination of blood color(brownish). 3. pulse oximetry to test saturation of blood oxygen. 4. dna sequencing of the globin chain can be used to identify hbm. heme biosynthesis heme is the iron protoporphyrin, synthesized mostly in the bone marrow (85%) and liver because of the requirements for incorporation into hemoglobin and the cytochromes, respectively. the initial and last three enzymatic steps are catalyzed by enzymes that are present in mitochondria whereas the intermediate steps are taking place in cytoplasm. steps of heme synthesis: 1. synthesis of 5-aminolevulinic acid (ala) in the mitochondria by ala synthase enzyme, succinyl coa condenses with glycine to form a-amino-b-ketoadipic acid in presence of vitamin 8, which activate glycine. by the same enzyme a-amino-f- ketoadipic acid is decarboxylated to form 6-aminolevulinic acid (ala) cooh an cooh . ch, ch, succinyl=coa { ? ] ! cocenate) ch, ch, an cha =0 coa:sh =0 4 =0 poesseses 4 i | 's-coa fj, h- c-nhq h-c-nh, h coo |h h ame {itn a-amino-6-ketoadipic -aminolevulinic acid * cooh acid figure 13. synthesis of 5-aminolevulinic acid 25"
    },
    {
        "page": 28,
        "text": "chapter ii. red blood corpuscles 2. synthesis of porphobilinogen (pbg). in the cytoplasm 2 molecules of ala condense together with removal of 2 molecules of water by ala dehydratase enzyme to form porphobilinogen (pbg) ala dehydratase is zinc containing enzyme inhibited by lead. cooh cooh i coch ch cooh ch: 2h,0 ae us ch, oo. ch, z f 2 bee ie : ye =0 h3c-h dehydratase k no ch; saa la h \\ z nh; nh two molecules of ; porphabilinogen -aminolevulinate (first precursor pyrrole} figure 14. synthesis of porphobilinogen 3. synthesis of uroporphyrinogen in the cytosol four molecules of porphobilinogen condense together by uroporphyrinogen | synthase to form an open-chain tetrapyrrole which can spontaneously form uroporphyrinogen |, the linear tetrapyrrole in presence of uroporphrinogen ill cosynthase produces the asymmetrical isomer uroporphyrinogen i. 4 moleclules of porphobilinogen uroporphyrinogen synthase 4 nh, linear tetrapyrrole uroporphyrinogen i cosynthase a p a a p p p ry uroporphyrinogen type hi (a= acetate group and p= propionate group ) figure 15 synthesis of uroporphyrinogen 26"
    },
    {
        "page": 29,
        "text": "chapter ii. red blood corpuscles 4 ..synthesis of coproporphyrinogen in cytosol all acetate groups (a) are decarboxylated to methyl substituents (m) 4c0? p m uroporphyrinogen [i] coproporphyrinogen [ik figure 16. synthesis of coproporphyrinogen 5. synthesis of protoprphyrinogen ii|, protoporphyrin and heme in mitochondrial coproporphyrinogen oxidase which acts only on type i oxidizes and decarboxylates two propionic side chains in rings | and ii to vinyl groups(-ch=ch,) and protoporphyrinogen i is formed. protoporphyrinogen (4 methylene bridges -ch.,-), by oxidase forms protoporphyrin (4 methenyl bridges ch=), and then by heme synthase (ferrochelatase) heme is formed. regulation of heme synthesis 1. ala synthase enzyme controls the rate-limiting step of heme synthesis. heme and also hematin act as a repressor of the synthesis of ala synthase and act as feed-back inhibitor at this step, the inhibition occurs at an allosteric site. 2.the block in heme biosynthesis in pantothenic acid or vitamin b6 deficiency occurs at very early step in heme synthesis (ala synthase). 3.ala dehydratase is sulfhydryl enzyme and is very sensitive to inhibition by heavy metals as mercury or lead. aa 27"
    },
    {
        "page": 30,
        "text": "chapter ii. red blood corpuscles m p mt v 2002 m m coproporphyrinegen m m p p oxidase (07) pp v oxidation ) p m +decarboxylation p m coproporphyrinogen i protopoarphyrinogen iil i m v 6h (02) protoporphyrinogen m m oxidase pp vv pp m n.b.* porphyrinogens are colourless contain 6 extra hydrogen atoms compared to coloured porphyrins * heme synthase is inhibited by lead . m y . . imidazole of distal histidine er polypeplide chain (globint figure 17a. synthesis of protoprphyrinogen ill, protoporphyrin and heme 28"
    },
    {
        "page": 31,
        "text": "chapter ii. red blood corpuscles disorders of heme biosynthesis (porphyrias) they are a group of disorders due to abnormailities in the pathway of biosynthesis of heme; they can be genetic or acquired. also, porphyrias can be classified according to organs or cells that are most affected into hepatic and erythropoietic or both. the clinical signs and symptoms of porphyria result from either deficiency of metabolic products beyond the enzymatic block of hb biosynthesis or from an accumulation of metabolites before the block. where the enzyme lesion occurs early in the pathway prior to the formation of porphyrinogens, ala and pbg will accumulate in the body causing toxic effects in abdominal nerves and in cns, resulting in abdominal pain and neuropsychiatric symptoms. on the other hand, enzyme blocks later in the pathway result in the accumulation of porphyrinogens (colourless), which upon oxidation produces the corresponding porphyrins (coloured) that cause photosensitivity. types of porphyrias: 1. congenital porphyrias 2. acquired (toxic) porphyrias. caused by exposure to toxic compounds as hexachlorobenzene and heavy metals as lead which inhibits ferrochelatase and ala dehydratase. patients suffer from severe anemia with accumulation of ala and coproporpyrin ill in urine. treatment 1. avoid exposure to sunlight 2. injection of hemin. 3. antioxidants and b-carotene. catabolism of heme: heme catabolism occurs in the reticuloendothelial cells by the complex enzyme called heme oxygenase in the presence of o2 and nadph (fig 17 b) 29"
    },
    {
        "page": 32,
        "text": "chapter ii. red blood corpuscles heme catabolism occurs in reticulo endothelial cells by the complex enzyme called heme oxygenase in the presence of o2 and nadph. oo s ren nadph 0) nadp, fe\" 4 co made nadp heme biliverdin ma a pe bilirubin heme oxygenase (green) biliverdin (yellow) (produces cleavage of c methenyl bridge) reductase res alfvariaia? 4.- blood vv. hemobilirubin ( indirect} i albumin 2udp 2udp-glu liver de an cholebilirubin { direet) bilicubin-glucurony! transterase bile sc cee z i ; ec oe e bilirubin cholebilirubin bilirubin p lirobilinogen r sterenlitin or intestine urobilin figure 17 b. catabolism of heme ii-g. iron turnover fate of rbcs the red blood cells regularly exit from arterioles in the splenic pulp and travel through small pores to enter the splenic sinus where old red blood cells are sorted out and destroyed (figure 18-a). macrophages in spleen, liver, bone marrow,etc, engulf and break down the cell fragments. hemoglobin is released from the cells and split into globin and heme. the globin portion is hydrolyzed into amino acids, which are reutilized for protein synthesis. the heme is converted to biliverdin and bilirubin (bile pigments; normally ~0.2-0.8 mg/dl blood) that are excreted in the bile while iron is reutilized for hemoglobin synthesis (figure 18-b). 30"
    },
    {
        "page": 33,
        "text": "chapter ii. red blood corpuscles a circulation , 3c formation 3 x 10*red blood cells 900 g hemoglobin oe 1x10'rbc 1x10 rbc a b 0.3 g hemoglobin 0.3 g hemoglobin come per hour per hour actor | actor | = system down gd. om _ spleen \\ a i ne bile pigments *s, in stool, urine ig > tate =a f i ak small amount oo wy of iron o geet cae in: bone marrow lymph nodes spleen liver, etc. artes figure 18. life cycle of red blood cells lron balance in adults, the amount of iron lost from the body is relatively small. men lose about 0.6 mg/day, largely in the stools. women have a variable, larger loss averaging twice this value because of additional iron lost in menstruation. the average daily iron intake is about 20 mg. iron absorption almost all iron absorption occurs in the duodenum. not all ingested iron is absorbed. intestinal absorption of iron is regulated by three factors: recent dietary intake of iron, the state of the iron stores in the body, and the state of erythropoiesis in the bone marrow. organ meats as liver, heart and kidney and also egg yolk, whole wheat, spinach and molasses are good sources of iron. milk is a poor source of iron. most of the iron in the diet is in the ferric (fe*+3) form, but it is the ferrous (fe*2) form that is absorbed (figure 19). gastric secretions and ascorbic acid aid iron reduction to the fe2 form. therefore, iron deficiency anemia is a frequent complication of partial gastrectomy. factors that help iron absorption 1) acidity, as the low ph helps to liberate iron from organic combinations; 2) reducing agents, e.g. vitamin c and glutathione change iron from the ferric state (fe**) to ferrous state (fe*?); 3) proteins specially those containing sulfur containing amino acids also change iron from ferric to ferrous; 4) type of iron compounds in the diet: heme iron is absorbed directly. 5) iron deficiency enhances iron absorption. 31"
    },
    {
        "page": 34,
        "text": "chapter ii. red blood corpuscles factors which inhibit iron absorption are 1) achlorhydria or hypochlorhydria. 2) phytates. 3) oxalates. mechanism of iron absorption in the duodenum transport of fe into enterocytes occurs via divalent metal transporter 1 (dmt1) in the apical (luminal) side of the cell (figure 19). heme is transported to the enterocytes as such by binding to another apical transport protein, heme transporter (ht). in the enterocyte cytoplasm, heme oxygenase (ho2) removes fe from the porphyrin of heme and adds it to the intracellular fe pool. some fe is stored in ferritin in the enterocytes; the remainder is transported to plasma by the transporter ferroportin 1 (fp). brush border intestinal - enterocyte blood lumen heme fes* reductase fe2* fe ferritin fe3* fe3*-tf figure 19. iron absorption fe3+ is converted to fe2+ by ferric reductase, and fe2+ is transported into the enterocyte by divalent metal transporter 1 (dmt1). heme is transported into the enterocyte by a separate heme transporter (ht), and heme oxygenase (ho2) releases fe2+ from the heme. some of the intracellular fe2+ is converted to fe3+ and bound to ferritin. the rest binds to ferropontin (fp) and is transported to plasma. in plasma, fe2+ is converted to fe3+ and bound to transferrin (tf). fate of the absorbed iron iron released from the mucosal cells enters the portal blood as ferrous (fe+2) ions. in plasma, fe2+ is converted to fe3+ and is bound to the iron transport protein transferrin (tf). the oxidation occurs by serum ferroxidase (ceruloplasmin). the protein bound iron is 50-150 g/dl, but the total iron binding capacity (tibc) is 300 to 360 *g/dl. thus, normally, transferrin is about 35% saturated with iron. 32"
    },
    {
        "page": 35,
        "text": "chapter i. red blood corpuscles iron is taken rapidly by the bone marrow for hemoglobin synthesis. the remaining iron is stored in the liver as hemosiderin. daily iron requirements infants (10-15 mg/day) children (15 mg/day) adolescent males 11-18 years (18 mg/day) adult males (10 mg/day) females up to 50 years (18 mg/day) after 50 years, 10 mg/day. the increased demands for iron in the females are due to pregnancy, menstruation and lactation. lron distribution the total body content of iron is about 5 g. hemoglobin contains 3 g of the total body iron (60%). 5% of total iron is held by a porphyrin combined with proteins, e.g. myoglobin, cytochromes, cytochrome oxidases, catalase and peroxidase. lron is stored as ferritin. liver is the main organ for storage of iron. plasma iron level varies between 50-150 pg/dl. lron excretion iron is excreted mainly by the faeces either as unabsorbed iron or sloughed intestinal cells. functions of iron 1. iron is important for compounds essential for cellular respiration as hemoglobin and tissue iron (e.g. myoglobin, cytochromes, cytochrome oxidase, catalase and peroxidase). 2. the remaining iron is present in stored form as ferritin, transferrin and hemosiderin and used in hemoglobin biosynthesis. abnormal iron levels lron deficiency: this condition may be due to diminished intake, diminished absorption or increased loss of iron. it is characterised by hypochromic microcytic anemia with decreased protein bound iron, increased total iron binding capacity and serum ferritin less than 20 pg/ml. iron deficiency anemia is common in infancy as milk is deficient in iron. lron toxicity (hemosiderosis): excessive accumulation of iron in tissues, e.g. spleen, heart, liver, pancreas and under the skin (hemochromatosis) due to repeated blood transfusion in hemolytic anemia. this condition may lead to bronze diabetes. the condition is characterised by decreased total iron binding capacity and serum ferritin is more than 50 pg/ml! . 33"
    },
    {
        "page": 36,
        "text": "chapter i. metabolism of vitamins vital to blood health after studying this chapter the student will be able to: 1. discuss the role of folic acid in the human body. 2. identify the role of cobalamin in the human body 3. identify the role of vitamin k in blood clotting. 4. enumerate manifestations and causes of deficiency of cobalamin, folic acid, vit. k. and iron. folate and vitamin b12 are essential for dna maturation during erythropoiesis, hence their deficiency causes anemia. vitamin k acts as a co- factor in synthesis of several clotting factors in the liver, and its deficiency causes bleeding tendency. this chapter outlines the metabolism of these 3 vitamins."
    },
    {
        "page": 37,
        "text": "chapter i. metabolism of vitamins vital to blood health -a. folic acid: (folacin=| lutamic acid) chemistry it is formed of pteridine nucleus (bicyclic nitrogenous compound), p-amino benzoic acid (paba), and glutamic acid. animal cells are not capable of synthesizing paba or of attaching the first glutamate to pteroic acid, but bacteria and plants can, thus animals require folic acid in their diet. requirements: 200 ug/day. sources the major source is leafy vegetables. other good sources are yeast, cauliflower, liver and kidney. by oe ch, | i, ch, folic ae acid {ss glutamic acid pteroyl (pteroic acid) pterdne h gh, a . ( n gh nadph +h folate paba 5 coo- nadp* folic acid hn 7 trimethoprim or as. methotrexate binydroteae acid nadph + h+ nadp+ h2n 7 oe - tetrahydrofolic acid (h,folate) figure 20. folic acid (top) and tetrahydrofolate (right) folate reductase 35"
    },
    {
        "page": 38,
        "text": "chapter i. metabolism of vitamins vital to blood health functions formation of the important coenzyme tetrahydrofolic acid (fh,). this is accomplished by folic acid reductase enzyme that needs nadph + h* (reduced co ii) as a hydrogen donor. fh, (h, folate is the coenzyme for one carbon metabolism. the one carbon moiety carried on fh, may be: methyl (-ch,) methylene (- ch,-), methenyl (-ch = ), formyl (-cho), or formimino (-ch = nh) moiety. sources of the one carbon group 1. beta-carbon of serine, is considered the major source. 2. glycine. 3. formate (e.g. intermediary metabolism of tryptophan through kynurenine pathway). functions of one carbon group various one carbon tetrahydrofolate derivatives are used in biosynthetic reactions, for example: 1. synthesis of some amino acids as glycine, serine, methionine, and histidine. 2. purine biosynthesis (formation of carbon 2 and carbon 8 of purine ring). it is coenzyme for formyl transferase. 3. synthesis of deoxythymidylic acid (atmp). it is coenzyme for thymidylate synthase. sources of one-carbon units synthesis using one-carbon units senne serine glycine == methylene-thf > methyl-thf > methionine choline | tmp + dihydrofolate histidine > formimino-thf > methenyl-thf dna | form |-emethionine 7 y formate > formyl-thf > purines co, figure 21. sources and utilization of one-carbon substituted folates 36"
    },
    {
        "page": 39,
        "text": "chapter i. metabolism of vitamins vital to blood health deficiency folate deficiency may be true (primary), or it may be secondary to b,, deficiency. folate deficiency leads to: 1. macrocytic anemia associated with megaloblastic changes in bone marrow. inhibition of dna synthesis due to decreased availability of purines and dtmp, slows down the maturation of red blood cells, causing production of abnormally large macrocytic red blood cells with fragile membranes. 2. glossitis and gastrointestinal disturbances. folic acid antagonists these are substances used in treatment of malignant diseases (cancer) e.g. methotrexate (amethopterin) and aminopterin. they act by blocking snythesis of nucleic acids in malignant cells presumably by preventing the reduction of folic acid to tetrahydrofolic acid. i-b. cobalamin (vitamin b12) 1ogk ch, hoch, o figure 22. vitamin b12 __ 87"
    },
    {
        "page": 40,
        "text": "chapter i. metabolism of vitamins vital to blood health chemistry : it has two characteristic components: 1. the central portion of the molecule (corrin ring) consists of 4 reduced and extensively substituted pyrrole rings. it is very similar to porphyrin structure but differs from porphyrin in that 2 of the pyrrole rings (ring a and d) are joined directly rather than through a methene bridge. coordinated to the four inner nitrogen atoms of the corrin ring is an atom of cobalt. 2. the second component of vitamin b,, is 5,6-dimethyl benzimidazole riboside cobalt is in a coordination state of six. in the remaining position, it is coordinated to one of several different ligands: cyanide (cn), hydroxy (oh), methyl (ch,), or 5-deoxy adenosine to give in order: cyanocobalamin. hydroxycobalamin. methyl cobalamin 5-deoxyadenosyl cobalamin requirements: 2 ug/day sources: e the only source of cobalamin in nature is through synthesis by micro- organisms in animal intestine. e ingeneral it is not present in vegetable foods. e the only sources of the vitamin are foods of animal origin as liver, kidney, meats, milk and eggs, negligible amounts are provided by intestinal flora. neither animal nor plants can synthesize it. functions the two coenzyme forms of cobalamin are methyl cobalamin in the cytoplasm and 5-deoxyadenosyl cobalamin in mitochondria. /n man, there are only two biochemical reactions in which b,, is known to participate: 4. methylation of homocysteine to methionine occurs in the cytoplasm and utilizes methyl cobalamin as coenzyme and n-methyl thf as methyl source. 38"
    },
    {
        "page": 41,
        "text": "chapter i. metabolism of vitamins vital to blood health 2. isomerization of l-methy!l malonly coa to succinyl coa by the enzyme l- methyl malonyl coa mutase and the coenzyme 5-deoxyadenosyl cobalamin, which occurs in mitochondria. sh hc (ch,), (ch2)2 cee ie nhs ee oor homocysteine methionine methionine synthase methyicobalamin methyl h, folate h, folate hydroxocobalamin ch, ch, coo | hccoooo- hch | deoxyadenosylcobalamin | c s coa cscooa i methylmalonyl-coa i o mutase 0 l-methylmaionyl-coa succinyl-coa figure 23. reactions catalyzed by cobalamin coenzymes in mammalian tissues manifestations of vitamin b12 deficiency 1. pernicious anemia, which is characterized by: macrocytic megaloblastic anemia (thought to be due to the effect of b12 on folate metabolism) 2. neurologic disorders due to interference with myelin sheath integrity with sensory and motor losses (progressive demyelination of nervous tissue). decreased level of vitamin b12 results in decreased active form of methionine needed for methylation of phosphatidylethanolamine to bring phosphatidyl choline which is essential for myelin sheath formation. 3. homocystinuria and methyl malonic aciduria 39"
    },
    {
        "page": 42,
        "text": "chapter i. metabolism of vitamins vital to blood health i-c. vitamin k o ch ch, . eo chee ch, ch==cch,(ch;ch,chch,):h (ch,ch=cch,)4 o fe) viamin % vitamin kz figure 24. vitamin k sources e vitamin k, is abundant in vegetable oils and green leafy vegetables e.g. spinach, also in cabbage, cauliflower and peas. e vitamin k, is synthesized by intestinal flora and is found in animal tissues. e good sources of vitamin k include tomatoes, cheese, egg yolk, and liver functions e vitamin k is required for the conversion of several blood clotting factors (il, vil, ix and x) to the active state. e all these factors are proteins synthesized in the liver in an inactive precursor form. e the mechanism of vitamin k-dependent activation for prothrombin: prothrombin is synthesized in the liver in an inactive precursor form called preprothrombin. conversion of prothrombin precursor to active prothrombin requires a vitamin k-dependent carboxylation of specific glutamic acid residues to y-carboxyglutamic acid. eal co, -90 ccoo- t vv ge ch ch, vitamin k ch, | | -c--ch-n- -cch-n ii h i h o o figure 25. vitamin k-dependent carboxylation of prothrombin precursor to prothrombin 40"
    },
    {
        "page": 43,
        "text": "chapter i. metabolism of vitamins vital to blood health the y-carboxygulatmic acid residues are good chelators and allow prothrombin (active) to bind (chelate) calcium. the prothrombin-ca-complex in turn binds to the phospholipid membrane, where proteolytic conversion to thrombin can occur ca* 0. oo we) (e] wa gh ch, -c-ch-n- i h figure 26. the chelation of calcium ion by the y--carboxy glutamyl residue in clotting factor proteins. to summarize 1. vitamin k is an essential cofactor for the carboxylase enzyme that forms y-carboxygluatmic acid residues from the glutamic acid residues in the specific protein molecules. 2. apart from the clotting process vitamin k probably acts as a cofactor in oxidative phosphorylation (coenzyme q, an essential component of oxidative phosphorylation, is similar to vitamin k in structure). n.b.: vitamin k is an antidote to the dicumarol anticoagulant. deficiency e tis manifested by bleeding tendency. 41"
    },
    {
        "page": 44,
        "text": "chapter iv. anemia and polycythemia after studying this chapter the student should be able to: 1. outline the etiologic classification of anemia 2. describe how the pathophysiology of anemia determines red cell morphologic abnormalities explain how hereditary hemoglobin defects trigger hemolytic anemia discuss the different types, frequency and pathophysiology of nutritional anemias define aplastic anemia and list some of its causes classify types of anemia according to rbc morphologic changes define polycythemia and differentiate between primary and secondary polycythemia explain how high altitude and other hypoxic conditions trigger secondary polycythemia on haa w case study a 50-year-old man comes to his physician complaining of fatigue. he says that climbing the stairs leaves him short of breath and this has been getting progressively worse over the past month. the patient works in a stressful job and to relieve stress he smokes and drinks 6 cups of coffee a day. he has been taking aspirin for the last 6 months for frequent knee pain. his tests revealed: hematocrit: 30% red blood cell smear: microcytic hypochromic cells serum iron: 27 p g/dl transferrin saturation: 13% stool test: positive for occult blood diagnosis and treatment the patient is diagnosed with iron-deficiency anemia caused by chronic blood loss from a stomach ulcer that was exacerbated by repeated aspirin intake. the bleeding is confirmed by presence of occult blood in stools. the ulcer is treated medically and the patient prescribed iron tablets with vitamin c to aid iron absorption. this chapter discusses the causes and features of anemia and polycythemia."
    },
    {
        "page": 45,
        "text": "chapter iv. anemia and polycythemia iv-a. anemias anemia means a deficiency of red blood cells and / or decreased hemoglobin concentration 2 grams below the normal mean for a person, i.e. below 14 g/dl for men and below 12 g/dl for women. causes of anemia 1. loss of red blood cells e.g. blood loss anemia 2. destruction of red blood cells e.g. haemolytic anemia 3. decreased or defective production of red blood cells by the bone marrow e.g. aplastic anemia and nutritional anemias 1. acute loss of red cells as in sudden haemorrhage (car accidents, surgery). 2. chronic loss of red blood cells as in bleeding gums, peptic ulcer, bleeding piles and excessive uterine bleeding. this can result from several factors. a- hereditary abnormalities of red blood cells * sickle cell anemia the cells contain an abnormal type of hemoglobin called hemoglobin-s. when this hemoglobin is exposed to low o, concentrations, it precipitates into long crystals inside the red cells. these crystals elongate and cause the red cells to become sickle-shaped, hemolyze, and form aggregates that block blood vessels (figure 27-a). thalassemias * hereditary spherocytosis: in which the rbcs are not biconcave but spherical. + favism deficiency of glucose-6- phosphate dehydrogenase enzyme . acute hemolysis is induced by eating fava beans. b- hemolytic disease of the newborn. erythroblastosis fetalis (figure 27-b),where the rh-positive red cells in the fetus are destroyed by antibodies from an rh-negative mother. c- infections such as malaria. d- reactions to certain drugs, e.g. sulphonamides. e- autoimmune disorders. the body forms antibodies against its own red blood cells. 43"
    },
    {
        "page": 46,
        "text": "chapter iv. anemia and polycythemia 3. aplastic and nutritional anemias a- aplastic anemia bone marrow aplasia means lack of a functioning bone marrow. this could result from excessive x-ray or gamma ray irradiation, industrial chemicals or drugs. b- nutritional anemias deficiency of iron, proteins, vitamin b12 or folic acid can lead to very slow production of the erythroblasts in the bone marrow and thus, anemia may develop. microcytic, hypochromic anemia erythroblastosis fetails megaloblastic anemia figure 27. red cell appearance in different types of anemia morphologic classification of anemias according to red cell volume (mean corpuscular volume; mcv) and mean cell hemoglobin (mch) (figure 28), anemia is classified into: 1- normocytic normochromic anemias occur in acute haemolytic anemia and in acute blood loss. characteristics a. decreased red cell count 44"
    },
    {
        "page": 47,
        "text": "chapter iv. anemia and polycythemia b. decreased blood hemoglobin concentration c. decreased hematocrit d. the red cells are of normal size (normocytic) and of normal hemoglobin content (normochromic). cehtrifugation | blood sample mch(mean hb mass/rbc) = sli cic normal:30+ 3 red cell count picogram hematocrit ee (l fole] ) rec! li to0d mcv(mean volume of one rbc) ns het a | hemoglobin concentration =_snoormall:877 6 (qlleiooa) red cell count cubic micron red cell count (rcc) (quantity/l,,. 4) mchc(mean hb conc. in rbcs) = _b cone. normal: 34 g/dl hct figure 28. measurement of red cell indices 2- microcytic hypochromic anemias they are most often due to iron deficiency in the diet or chronic blood loss with loss of large amounts of iron over a long period. characteristics a- red blood cells are small in size (microcytic). b- the hemoglobin content of each cell is less than normal (hypochromic; figure 27-c) c- the red cell count is slightly reduced. 45"
    },
    {
        "page": 48,
        "text": "chapter iv. anemia and polycythemia 3- macrocytic normochromic anemias these are associated with megaloblastic erythropoiesis due to deficiency of vitamin b12 and folic acid. deficiency of either vitamin b12 or folic acid causes maturation failure in the process of erythropoiesis.vitamin b12 and folic acid are important for dna synthesis. lack ofthese vitamins causes abnormal and diminished dna and, consequently, failure of nuclear maturation and cell division. thus the erythroblastic cells of the bone marrow fail to proliferate rapidly, resulting in production of macrocytes, which are irregular, large, and oval instead of the usual biconcave disc. these poorly formed cells, after entering the circulation, are capable of carrying oxygen normally, but are fragile with a short life. characteristics . red cells are large in size (macrocytic). . the hemoglobin content of each cell is normal (normochromic). . reduced red cell count. 20 ff d . decreased hematocrit. pernicious anemia pernicious anemia is a macrocytic anemia that is combined with nervous system abnormalities. it results from vitamin b12 deficiency. animal food is the main dietary source of vitamin b12. after ingestion, vitamin b12 normally combines with the intrinsic factor (a glycoprotein secreted by parietal cells of the stomach). it protects vitamin b12 from digestion by gastrointestinal enzymes, and facilitates its absorption in the ileum. once the b12- intrinsic factor complex is absorbed, the intrinsic factor is released and the vitamin is transferred to the plasma. vitamin b12 is stored in large quantities in the liver and is released slowly as needed by the bone marrow and other tissues. the normal liver can store enough vitamin b12 to meet the requirements for many months. the main cause of pernicious anemia is therefore defective vitamin b12 absorption, secondary to intrinsic factor deficiency. this occurs in cases of gastric mucosal atrophy, with deficiency of gastric secretions. characters of pernicious anemia 4. megaloblastic red celis (figure 27-d) 2. degenerative lesions of the spinal cord. these do not occur with isolated folic acid deficiency. 46"
    },
    {
        "page": 49,
        "text": "chapter iv. anemia and polycythemia iv-b. pol hemia definition an increase of red blood cells count and /or an increase of blood hemoglobin level 2 grams above the normal value. types of polycythemia a- primary polycythemia (polycythemia vera) it is a tumorous condition of the bone marrow causes excess production of red blood cells. b- secondary polycythemia (physiological) it occurs secondary to hypoxia leading to increase production of red blood cells, e.g.: 1- high altitude: the tissue become hypoxic due to decreased o2 tension in the atmosphere leading to increased production of erythropoietin which stimulates red cell formation by the bone marrow. 2- polycythemia of the fetus: the fetal hemoglobin has great affinity to o2 and it gives the tissues less o2 than adult hemoglobin leading to hypoxia, increased production of erythropoietin and polycythemia 3- pulmonary and heart diseases: failure of delivery of o2 to the tissues leads to increased production of red blood cells. effects of polycythemia an increase in red blood cell count increases the oxygen-carrying capacity of the blood. the increased red blood cells volume is detected by an increased haematocrit value . in severe polycythemia , the hematocrit value may reach 70% instead of the normal 45%. this would greatly raise the blood viscosity, increase the arterial blood pressure and the work done by the heart. it is also associated with sluggish peripheral circulation. 47"
    },
    {
        "page": 50,
        "text": "chapter v. blood groups and blood transfusion after studying this chapter the student should be able to: . explain the basis of classification of individuals into 4 abo groups identify the matching of donor-to-recipient blood groups, and its physiologic bases justify the rationale for crossmatching in addition to blood typing list complications of mismatched blood transfusion and their pathophysiology explain the physiologic importance of the rh antigen define erythroblastosis fetalis and how its manifestations link to its pathophysiology aapron> karl lanstairer in 1818, british obstetrician james blundell successfully transfused human blood for the first time, to a patient who had bled during childbirth. subsequently, several blood transfusions were done: some saved lives, while others ended in severe complications and death. the reason behind the often fatal blood transfusions became clear when karl landsteiner, an austrian physician, discovered the first 3 human blood groups, a, b, and c in 1900. blood type c was later changed to o. he received the nobel prize for physiology or medicine in 1930. his colleagues alfred decastello and adriano sturli added ab, the fourth type, in 1902. this chapter discusses blood groups and blood transfusion."
    },
    {
        "page": 51,
        "text": "chapter v. blood groups and blood transfusion v-a. blood groups hundreds of different antigens have- been found on the surfaces of human blood red cells. most of these are weak and are mainly of importance in genetic studies, however, two particular groups of antigens are more likely than others to cause blood transfusion reactions. these are the so-called o- a-b system and rh system. o-a-b blood groups two related antigens (type a and type b) occur on the surfaces of the red blood cells in a large proportion of the population. strong antibodies that react specifically with either type a or type b antigens almost always occur in the plasmas of persons who do not have the antigens on their red blood cells. these antibodies can bind with the red cell antigens to cause agglutination (clumping together) and haemolysis of red blood cells. therefore, type a and type b antigens are called agglutinogens and the plasma antibodies are called agglutinins. individuals are normally classified into 4 major o-a-b types depending on the presence or absence of the two agglutinogens. rbc plasma blood blood antigens antibodies that can be group (agglutinogens) illustration (agglutinins) received ab a a none a, b, ab,o b ' (universal a recipient) b b rans i- andict . \\ . << anti-a (a) b,o bs a a anti-b : 1 - m4 anti-b (b) a, o fe) none anti-a (a) o(universal | wf s 5 < a anti-b (b) donor) anti-b a. anti-a at figure 29. agglutinins and agglutinogens in the different blood types 49"
    },
    {
        "page": 52,
        "text": "chapter v. blood groups and blood transfusion table 1. relative frequencies of different blood types blood type frequency (%) o 46 a 42 b ab it is obvious from the percentages in table 1 that the o & a genes occur frequently whereas the b-gene is infrequent. dangerous hemolytic transfusion reactions occur when blood is transfused into an individual with an incompatible blood type; that is, an individual who has agglutinins against the red cells in the transfused blood. the plasma in the transfusion is usually so diluted in the recipient that it rarely causes agglutination. however, when the recipients plasma has agglutinins against the donors red cells, the cells agglutinate and hemolyze. rh blood groups rh is a system composed primarily of the c, d, and e antigens, although it actually contains many more. d is by far the most antigenic component, and the term rh-positive is generally used to the individual that has agglutinogen d , whereas those persons who do not have type d-antigen are said to be rh negative. approximately 85% of all white races are rh positive and 15% are rh negative, in american blacks, the percentage of rh positive is 95, whereas in african blacks it is about 100%. thus, persons with type ab rh positive blood are \"universal recipients because they have no circulating agglutinins and they can take blood from any type without developing transfusion reactions. type o rh negative individuals are universal donors\" because there are no agglutinogens in their blood and thus can be given to any one without producing transfusion reactions due to o-a-b or rh incompatibility (figure 29). importance of the rh factor 1. before blood transfusion when an rh-negative person is injected with red blood cells containing rh factor, anti rh agglutinins develop very slowly. the maximum concentration of agglutinins occurs 2-4 months later. on subsequent transfusion of rh positive blood into the same person, a very high 50"
    },
    {
        "page": 53,
        "text": "chapter v. blood groups and blood transfusion amount of anti rh agglutinins develops and severe transfusion reactions will occur. 2. haemolytic disease of the newborn (erythroblastosis fetalis): when the mother is rh negative and father is rh positive, if the fetus has inherited the rh positive antigen from the father, eythroblastosis fetalis may result. small amounts or fetal blood may leak into the maternal circulation at the time of delivery. some mothers develop significant amounts of anti rh agglutinins after labour. the first baby is usually born normal. during the next pregnancy, the mother anti rh-agglutinins diffuse through the placenta into the fetus and can cause agglutination and haemolysis of the fetal red blood cells. if the haemolysis is severe, the infant may die in utero or may develop erythroblastosis fetalis. the main manifestations of erythroblastosis fetalis are: 1. anemia. 2. severe jaundice. 3. many immature red blood cells (erythroblasts) in the fetal blood. 4. kernicterus: a neurologic disease may develop due to deposition of bile pigments in some centres (motor areas) causing their damage. bile pigments do not enter the brain in the adult, but in the fetus and new borns the blood. brain barrier is not yet developed. prevention of erythroblastosis fetalis it is possible to prevent it from occurring the first time by administration of single dose of anti rh antibodies in the form of rh immunoglobulins after labour (within 72 hours postpartum period). such passive immunization prevents active antibody formation by the mother. this has to be done every pregnancy, every abortion or any cause of fetomaternal haemorrhage as severe trauma. v-b. blood transfusion indications of blood transfusion 1. circulatory shock: loss of large amounts of blood e.g. haemorrhage causes severe drop of arterial blood pressure. 2. severe anemia. 3. severe leukopenia. 51"
    },
    {
        "page": 54,
        "text": "chapter v. blood groups and blood transfusion 4. haemorrhagic diseases: deficiency of some coagulation factors as in haemophilia or decrease of blood platelets count below 50.0 cell/cmm as in thrombocytopenic purpura. transfusion of blood components several components of blood can be isolated and transfused alone, such as: 1- plasma transfusion can be used to supply coagulation factors in known coagulation factor deficiency (e.g.haemophilia). 2- platelet transfusion is indicated to prevent haemorrhage in patients with severe thrombocytopenia or platelet function defects. 3- red cell transfusion can be used for correction of intractable anemia by supplying rbcs without causing volume overload. steps done before blood transfusion 1. determination of abo and rh blood groups. 2. cross matching cross-matching in cross-matching, donor red cells are mixed with recipient plasma on a slide and checked for agglutination. it is advisable to check the action of the donors plasma on the recipient cells in addition, even though, as noted above, this is rarely a source of trouble. lf agglutination occurs in any one of the two slides or both, then these bloods are not compatible and blood transfusion should not be performed. the aim of this procedure is to detect the presence of any possible unknown agglutinogens that would cause transfusion reactions due to incompatibilities in systems other than abo and rh. thus, blood should never be transfused without being cross matched except in the most extreme emergencies. transfusion reactions resulting from mismatched transfusion 1. haemolytic transfusion reaction when one type of blood is transfused to a recipient of an incompatible blood type, a haemolytic transfusion reaction is likely to occur as the red blood cells of the donor blood are agglutinated, haemolysed then phagocytosed by the tissue macrophage system where hemoglobin is released. 52"
    },
    {
        "page": 55,
        "text": "chapter v. blood groups and blood transfusion fate of released hemoglobin a. hemoglobin released from the red cells is converted by phagocytes into bilirubin that is excreted into the bile by the liver. the concentration of bilirubin in the body fluid rises high enough to cause jaundice, i.e. the person's tissues become tinged with yellow bile pigments. b. some of free hemoglobin can leak through the glomerular membranes into the kidney tubules leading to acute renal failure. 2. acute renal failure one of the most fatal effects of transfusion reactions is acute kidney failure that seems to result from three different causes: a) renal ischemia: the haemolysedcells release toxic substances that can cause powerful renal vasoconstriction leading to renal ischemia. b) circulatory shock:the loss of circulating red blood cells along with production of toxic substances from hemolysed cells (e.g.histamine) can cause severe drop of abp. thus, the renal blood flow and urinary output decrease leading to circulatory shock. c) blockage of renal tubules: if the total amount of free hemoglobin in the circulation is greater than that which bind with haptoglobin ( a plasma protein that can bind small amount of hemoglobin) much of itleaks through the glomerular membranes into the renal tubules blocking some of them. all these factors can lead to acute renal failure and if the failure is complete, the patient may die within a week or two unless properly treated. autologous transfusion in order to eliminate the risk of transfusion reactions and prevent transmission of infectious blood-borne diseases, autologous transfusion is sometimes done. in this popular procedure, withdrawal of the patients own blood in advance of elective surgery is done. then, it is infused back to the same patient during the surgery if needed. 53"
    },
    {
        "page": 56,
        "text": "chapter vi. platelets and hemostasis after studying this chapter the student should be able to: describe the general and histological features of blood platelets. list and identify different stages of thrombopoiesis. outline the stages of hemostasis following blood vessel injury explain the factors leading to vascular spasm following vessel injury discuss how structural characteristics of the platelet membrane are linked to their physiologic role in hemostasis 6. describe the stages of platelet plug formation 7. illustrate the intrinsic, extrinsic and common pathways of blood clotting 8. discuss the possible fates of a blood clot 9. list the natural factors that prevent clot extension in case of injury 10. deduce the physiologic factors that prevent blood clotting in non-injured vessels 11. classify bleeding and thrombotic disorders 12. discuss causes and manifestations of hemophilia and itp as examples of bleeding disorders a ron: case study a 3-year-old boy is brought to the pediatrician by his parents, who have noted excessive bleeding around the knees and elbows. the parents have noted that the toddler bleeds very easily when the skin is scratched. family history is significant for the presence of hemophilia in the mothers family. his tests revealed the following: laboratory studies e hemoglobin: 10.9 g/dl (normal: 13.4-17.4 g/dl) e hematocrit: 32% (normal: 40%-54%) e platelets: 200,0/mm3 (normal: 150,0-400,0/mm3) e clotting time: 16 mins (normal 5-10 mins) e aptt (activated partial thromboplastin time): 42 sec (normal: 26.4-35 sec) e bleeding time: 2 min (normal: 1-3 min) efactor vi level: 5% (normal: 25%-100%) outcome a diagnosis of hemophilia a was made. the boys condition improved with regular intravenous infusion of recombinant factor vi. this chapter outlines the cells and systems that operate to prevent of blood loss following injury, and their elaborate regulatory mechanisms"
    },
    {
        "page": 57,
        "text": "chapter vi. platelets and hemostasis vi-a. characteristics of mature platelets they are so called as they appear in blood films as small flat plates. in lower vertebrate, they are called thrombocytes. however, this name is not true for mammalian platelets which are non-nucleated discs. platelets cannot reproduce. normal platelet count is 150,0-400,0/ mm3. lm picture (figure 30) - shape: non- nucleated biconvex discs. - diameter: each is about 2-3um in diameter. - ablood platelet has granular central region, the granulomere which contains reddish-purple (azurophilic) granules. - atthe periphery, there is a pale basophilic zone, the hya/lomere. em picture shape: when activated irregular outline due to presence of pseudopodia which serve for motility. - the platelet membrane: is covered by a well-developed glycoprotein - coatthat plays an important role in platelet function. hyalomere microtubules plasma membrane delta granules surface-opening tubule dense tubular system granulomere diagrammatic cut section figure 30. the blood platelet 55"
    },
    {
        "page": 58,
        "text": "chapter vi. platelets and hemostasis the hyalomere contains: e anetwork of actin and myosin filaments that causes contraction of the platelet for motility and for clot retraction. e acircumferential bundle of microtubules which maintains the discoid shape of platelets. e 2systems of membranes which are involved in regulation of the intra- platelet calcium concentration and thus the control of platelet degranulation. these are: a- the open canalicular system, formed of membrane -bounded small canaliculi that open on the platelet surface. b- the dense tubular system formed of remnants of the endoplasmic reticulum of the platelets mother cell (the megakaryocyte). the granulomere contains: e fewribosomes, mitochondria and glycogen particles. e three types of membrane- bounded granules which are released by exocytosis during the process of thrombus formation. these are: 1. alpha granules: these are abundant, large granules which contain fibrinogen and other coagulation factors. 2. delta granules: these are less abundant, medium- sized granules which contain histamine, serotonin, atp, adp. 3. lambda granules (lysosomes): these are few small dense granules that contain lysosomal hydrolytic enzymes. 56"
    },
    {
        "page": 59,
        "text": "chapter vi. platelets and hemostasis vi-b. thrombopoiesis it is the formation of blood platelets. the release of mature platelets from the bone marrow into the bloodstream takes about 10 days (figure 31). stem cell developmental pathway > vw ~ % cfu- meg megakaryoblast promegakaryocyte megakaryocyte platelets figure 31. thrombopoiesis blood platelets formation passes through the following stages: 1. phscs. 2. mhscs. 3. colony forming unit-granulocyte/erythrocyte/monocyte/megakaryocyte (cfu- gemm). 4. colony forming unit- megakaryocyte (cfu- meg). 5. megakaryoblasts. 6. megakaryocytes- - giant cells (50-150um). - the nucleus is large, lobulated containing the polyploid number of the ordinary dna sets. - the cytoplasm is basophilic and filled with many organelles as well as the alpha, delta and lambda granules. - ultrastructurally, the cytoplasm shows membranous demarcation lines surrounding groups of granules. these are the lines of cleavage of the megakaryocytes into platelets (about 1200 platelets per megakaryocyte). - megakaryocytes are located near the bone marrow sinusoids, into which they extend their cytoplasmic processes to release the platelets in bloodstream. 57"
    },
    {
        "page": 60,
        "text": "chapter vi. platelets and hemostasis vi-c. hemostasis hemostasis means prevention of blood loss or stoppage of bleeding. whenever a vessel is ruptured, hemostasis is achieved by several mechanisms. mechanisms of hemostasis 1-vascular spasm immediately after a blood vessel is cut, the vessel wall contracts; this reduces blood flow from the ruptured vessel. the contraction results from: a- nervous reflexes initiated by pain b- local myogenic contraction of the blood vessels c- humoral factors from the traumatized tissues and platelets. platelets mediate much of the vasoconstriction by releasing the vasoconstrictor substances, thromboxane a2 and serotonin. this local vascular spasm can last for many minutes or even hours during which the process of platelet plugging and blood coagulation can take place. 2-formation of the platelet plug when the receptors on the platelet membrane come in contact with damaged endothelium or collagen fibres in the vascular wall, the platelets immediately change their shape (figure 32). they become sticky and develop finger-like processes, so that they stick to the collagen fibres, a process called platelet adhesion. this is followed by platelet activation. activated platelets release the contents of their dense granules, including adp, thromboxane a2 and serotonin. these 3 agents in turn act on nearby platelets to activate them, causing them to adhere to the originally activated platelets, resulting in platelet aggregation. thus, a platelet plug is formed, which is usually successful in stopping blood loss if the vessel opening is small."
    },
    {
        "page": 61,
        "text": "chapter vi. platelets and hemostasis figure 32. resting and activated platelets. resting platelets are smooth and discoid shaped (left). activated platelets (right) are swollen, sticky with finger-like processes, and secretory. if there is a large hole, a blood clot is required. 3-formation of the blood clot (coagulation) the clot begins to develop a few seconds after the vascular injury (figure 33). oe figure 33. fibrin clot entangling red blood cells (scanning electron microscope photo) coagulation factors are essential to coagulation. they are mostly plasma proteins (inactive proteolytic enzymes) synthesized by the liver. however, some are not protein (e.g. calcium ions) and some are released by the platelets. table 2 lists the different coagulation factors (names and their designated roman numerals)."
    },
    {
        "page": 62,
        "text": "chapter vi. platelets and hemostasis table 2. clotting factors factor xl xil xill hmw-k pre-k, ka pl names fibrinogen prothrombin thromboplastin calcium proaccelerin, labile factor, accelerator globulin proconvertin, spca, stable factor antihemophilic factor (ahf), antihemophilic factor a, antihemophilic globulin (ahg) plasma thromboplastic component (ptc), christmas factor, antihemophilic factor b stuartprower factor plasma thromboplastin antecedent (pta), antihemo- philic factor c hageman factor, glass factor fibrin-stabilizing factor, laki-lorand factor high-molecular-weight kininogen, fitzgerald factor prekallikrein, fletcher factor kallikrein platelet phospholipid a 4factor vi is not a separate entity and has been dropped. 60"
    },
    {
        "page": 63,
        "text": "chapter vi. platelets and hemostasis steps of coagulation a) formation of prothrombin activators (active factor x, active factor v, ca and phospholipids). this is done by either the intrinsic or the extrinsic pathways. b) conversion of prothrombin into thrombin (by prothrombin activators). c) conversion of soluble fibrinogen into insoluble fibrin threads (by thrombin). steps b and c are called the common pathway. * formation of prothrombin activators: in the body, two different pathways start coagulation: e the intrinsic pathway becomes activated when blood comes into contact with a rough surface (contact activation). \\n the lab, this occurs when putting blood into a glass test tube. e the extrinsic pathway is activated when blood comes in contact with material from damaged tissues (tissue factor activation). i.e. the stimulus is trauma to the blood vessel wail or surrounding tissues. in both cases, a chain reaction is triggered in which inactive coagulation factors in the circulation, are sequentially activated. the extrinsic and intrinsic pathways converge as they end by converting the soluble plasma protein, fibrinogen (coagulation factor |), to insoluble fibrin, the main constituent of the clot 61"
    },
    {
        "page": 64,
        "text": "chapter vi. platelets and hemostasis a. the intrinsic pathway (contact activation) | it starts by activation of factor xii by contact of blood with collagen fibers under the injured endothelium. this activation is catalyzed by high-molecular- weight kininogen and prekallikrein (figure 34). active factor xii then activates factor xi, and active factor xi aetivetes factor ix. activated factor ix forms a complex with active factor vi, which activates factor x. phospholipids from platelets (pl) and ca2+ are necessary for full activation of factor x. blood trauma or contact with collagen xil| > activated xil (xlla) < (hmw kininogen, prekalikrein) x| activated xi (xla) ++ ca ix _- activated ix (ixa) | vill thrombin ++ villa ca xxx > activated x (xa) platelet phospholipids thrombin catt v prothrombin platelet activator phospholipids prothrombin >> thrombin ++ ca figure 34. the intrinsic pathway of blood clotting"
    },
    {
        "page": 65,
        "text": "chapter vi. platelets and hemostasis b. the extrinsic pathway of blood clotting (tissue factor activation) phospholipids \\\\ i ] it is initiated by factors outside the vascular system. nonvascular cells express the membrane protein tissue factor (tissue thromboplastin, or factor ill). tissue factor acts as a receptor for factor vii, which is a plasma protein. when injury to the endothelium allows factor vii to come in contact with tissue factor, tissue factor activates factor vii (figure tissue factor, factor vila, and ca2+ form a complex that proteolytically activates factor x to factor xa. factor xa, which arises by both the intrinsic and extrinsic pathways, proceeds along the common pathway. tissue trauma tissue factor . activated x (xa) _ att <v prothrombin platelet activator & prothombin thrombin i catt figure 35. the extrinsic pathway of blood clotting 63"
    },
    {
        "page": 66,
        "text": "chapter vi. platelets and hemostasis c. the final common pathway e prothrombin activators (factor xa_ from the extrinsic or intrinsic pathway, factor va, ca2+ and phospholipids) convert prothrombin (factor il, one of the plasma proteins) into thrombin. e thrombin(proteolytic enzyme) catalyzes the conversion of soluble fibrinogen (factor |) to insoluble fibrin threads (figure 36). e thrombin first converts fibrinogen to fibrin monomers, then many fibrin monomers polymerize into fibrin threads that form the clot. this reaction requires ca. e thrombin also activates factor xi (fibrin-stabilizing factor), which mediates the covalent crosslinking of the fibrin polymers to form a mesh called stable fibrin that is even less soluble than fibrin polymers. prothrombin prothrombin activator thrombin fibrinogen > _insolube fibrin $i monomers [ ae fibrin fibers activated factor xill (fibrin-stacilizing factor) cross-linked fibrin fibers = figure 36. the final common pathway leading to fibrin formation 64"
    },
    {
        "page": 67,
        "text": "chapter vi. platelets and hemostasis nb. there is a_ cross-talk between the intrinsic and extrinsic pathways.after blood vessels rupture, clotting is initiated by both pathways simultaneously. however, the extrinsic pathway is very fast, particularly if a large amount of tissue factor is available, while the intrinsic one is much slower. role of calcium ions in the intrinsic and extrinsic pathways except for the first two steps in the intrinsic pathway, calcium ions are required for promotion or acceleration of all blood-clotting reactions. therefore, in absence of calcium ions, blood clotting does not occur by either pathway. in the body, the calcium ion concentration rarely falls low enough to impair blood clotting. but, reducing the calcium ion concentration in a blood sample prevents it from clotting (as detailed later). 4.clot retraction after 20-60 minutes of clot formation, the clot begins to contract and expresses most of the fluid from the clot. the fluid expressed is called serum, which is similar to plasma but without all its fibrinogen and most of the other clotting factors. thus serum cannot clot because of lack of these factors. platelets are necessary for clot retraction to occur. role of platelets in clot retraction a) they become attached to the fibrin threads in a way that they physically bind different threads together b) platelets entrapped in the clot secrete some of fibrin stabilizing factor (factor xi), which forms more cross-linking bonds between the fibrin threads. c) activation of the platelet contractile proteins can cause strong contraction of the platelets attached to the fibrin. course of the clot once a blood clot is formed, it can follow two separate courses: either it is invaded by fibroblasts that subsequently form connective tissue, or it can undergo lysis (i.e. dissolve). 65"
    },
    {
        "page": 68,
        "text": "chapter vi. platelets and hemostasis lysis of blood clot (fibrinolysis) plasma proteins contain an euglobulin called plasminogen (profibrinolysin) which when activated, is converted to plasmin (fibrinolysin). plasmin is a proteolyfc enzyme that digests fibrin threads and other substances in the clot such as prothrombin. thus plasmin can cause complete lysis (dissolution) of the blood clot. when a clot is formed, plasminogen is trapped in the clot along with other plasma proteins. this will not cause lysis of the clot until activated. the injured tissues and endothelium slowly release a powerful activator called tissue plasminogen activator (t-pa) that a few days later, after the clot has stopped the bleeding, converts plasminogen to plasmin, which removes the remaining unnecessary blood clot. many small blood vessels in which blood flow has been blocked by clots are reopened by this mechanism. plasminogen activators are used in treatment of cardiac and cerebral thrombosis to re-establish blood flow to these vital organs. factors that prevent clot extension normally, endogenous anticoagulant mechanisms prevent clots from becoming unnecessarily large by inhibition of activated clotting factors. this is accomplished by several systems that depend on an intact endothelial cell surface. 1. tissue-factor pathway inhibitor (tfpi) tfpi is a plasma protein that binds to the complex [tissue factor + factor vila + ca2+] in the extrinsic pathway and blocks the activity of factor vila. tfpi is linked to the endothelial membrane, where it maintains a natural anti- thrombotic surface. 2. antithrombin il! is a plasma protein that inhibits thrombin, and many other enzymes in the coagulation pathway. heparin, the natural anticoagulant contained in basophils and mast cell granules. it inhibits thrombin by enhancing the activity of antithrombin i. 3. proteinc this is another protein produced in the liver. it inhibits the activity of factors v & vill. healthy endothelial cells produce thrombomodulin, which binds to thrombin forming thrombomodulin- thrombin complex that activates protein c. 66"
    },
    {
        "page": 69,
        "text": "chapter vi. platelets and hemostasis 4. paracrine factors endothelial cells generate: e prostacyclin which promotes vasodilation and inhibits platelet activation. e nitric oxide which inhibits platelet adhesion and aggregation (released by the endothelium in response to thrombin). what prevents blood clotting in non-injured vessels? e clotting factors circulate in an inactive form e the glycoprotein coat of platelets repulses the normal endothelium e the healthy endothelium ensures that blood does not come in contact with negatively charged surfaces (e.g. collagen) that activate the intrinsic pathway. e blood does not normally come in contact with tissue factors that activate the extrinsic pathway. e rapid flow of blood does not allow any activated clotting factors to accumulate. e there are natural anticoagulants in plasma, including anti-thrombin i and heparin @ plasma contains plasminogen, which tissue plasminogen activator (t- pa) can convert to plasmin, a protease that digests fibrin and thereby lyses blood clots. role of vitamin k in coagulation vitamin k is a necessary cofactor for the enzyme that catalyzes one reaction in the synthesis of vitamin k-dependent coagulation factors in the liver. they are factor ii (prothrombin), vii, ix, and x. vitamin k deficiency impairs the formation of these factors, resulting in bleeding tendency. role of platelets in hemostasis they share in all steps of hemostasis (vascular spasm, platelet plug formation, coagulation and clot retraction) 67"
    },
    {
        "page": 70,
        "text": "chapter vi. platelets and hemostasis disturbed hemostasis can lead to either excessive bleeding or excessive coagulation .bleeding disorders arise from abnormalities that prevent normal clot formation while thromboembolic disorders result from undesirable clot formation. 1-bleeding disorder: the most common causes are platelet deficiency (thrombocytopenia) and deficits of some coagulation factors, which can result from impaired synthesis of these factors in the liver or certain genetic conditions. a.ldiopathic thrombocytopenic purpura idiopathic thrombocytopenic purpura is due to an autoimmune reaction where specific antibodies destroy the persons normal own platelets leading to decreased platelet count below 50,0 cell/ cmm. the bleeding time is very much prolonged (normal bleeding time is about 2-5 minutes) and the clot retraction is impaired. manifestations: persons with thrombocytopenic purpura have tendency to bleed, usually from many small capillaries rather than from large vessels. platelets are especially important for repair of minute breaks in capillaries and other small vessels. as a result, small punctate haemorrhages occur throughout all body tissues. the skin of such a person have many small purplish blotches giving the disease the name purpura (figure 37). it is treated by fresh whole blood transfusion as fresh blood contains viable blood platelets. figure 37. purplish spots in a patient with idiopathic thrombocytopenic purpura b. impaired liver function when the liver is unable to synthesize its usual supply of coagulation factors, as in advanced cirrhosis, abnormal bleeding occurs. 68"
    },
    {
        "page": 71,
        "text": "chapter vi. platelets and hemostasis c. vitamin k deficiency because vitamin k is produced by intestinal bacteria, dietary deficiency is rarely a problem. vitamin k deficiency occurs in newborns or in adults with impaired fat absorption, as in bile duct obstruction and after repeated intake of systemic antibiotics. this is because vitamin k is a fat-soluble vitamin that is absorbed into the blood along with fats, which depend on bile for their digestion. treatment is by vitamin k injections. d. hemophilias hemophilia is a genetic bleeding disorder that occurs almost exclusively in males. in 85% of cases, it is caused by deficiency of factor vi; this is hemophilia a, or classic hemophilia. in the other 15%, the bleeding tendency is caused by deficiency of factor ix. both types are x-linked conditions occurring primarily in males. symptoms of hemophilia begin early in life. prolonged bleeding after minor interventions such as tooth extraction is common. often joints become disabled and painful because of repeated bleeding into the joints after exercise or trauma (figure 38). hemophilias are managed by transfusions of fresh plasma, or preparations of the deficient factor made from plasma. more recently, factor vi has been produced by recombinant dna technique. figure 38. bleeding into a knee joint as occurs in hemophilia thromboembolic disorders thrombosis it is abnormal clotting inside intact blood vessels. thrombosis occurs particularly due to sluggish blood flow because it permits activated clotting factors to accumulate instead of being washed away. it also occurs when the intima of blood vessels is damaged by atherosclerotic plaques. 69"
    },
    {
        "page": 72,
        "text": "chapter vi. platelets and hemostasis embolism it occurs when bits of a thrombus (emboli) break off and travel in the bloodstream to distant sites, damaging other organs (e.g. obstruction of the pulmonary artery by emboli from the leg veins (pulmonary embolism). disseminated intravascular coagulation (dic) dic is a serious complication of septicemia, extensive tissue injury, and other diseases in which fibrin is deposited in the vascular system and many small- and medium-sized vessels are thrombosed. the increased consumption of platelets and coagulation factors causes bleeding to occur at the same time. the cause of the condition appears to be increased generation of thrombin due to increased tissue thromboplastin activity without adequate tissue factor inhibitory pathway activity. anticoagulants anticoagulants are used clinically in patients with thromboembolic disorders to prevent pathological clotting/thrombosis (i.e. in vivo). in addition, anticoagulants are also routinely used in blood samples used for laboratory testing, and in blood donated for transfusion (i.e. in vitro). in vivo anticoagulants heparin is a naturally occurring anticoagulant that facilitates the action of antithrombin ill. it is given parenterally and has a rapid anticoagulant action. coumarin derivatives such as dicumarol and warfarin are also effective anticoagulants. they inhibit the action of vitamin k, which is a necessary cofactor for the enzyme that catalyzes one reaction in the synthesis of vitamin k-dependent factors: ii, vii, ix, and x. they have the advantage of oral administration, but require 12-24 hours to act, since the circulating factors have to be consumed first. in vitro anticoagulants heparin can be used /n vitro as well as jn vivo. ca2+ is the fourth coagulation factor and is necessary for both extrinsic and intrinsic pathways. clotting can be prevented jn vitro if ca2+ is removed from the blood by: e deionizing the calcium by causing it to react with substances such as sodium citrate (non toxic) e precipitating the calcium with substances such as sodium oxalate (toxic) 70"
    },
    {
        "page": 73,
        "text": "chapter vii. white blood cells after studying this chapter the student should be able to: 1- classify the white blood cells. 2- describe the general and histological features of types of granular and agranular leukocytes. 3- correlate the staining property of the developing stages of granulopoiesis and lymphopoiesis in relation with the associated cytoplasmic changes. our bodies are exposed continually to bacteria, viruses, fungi, and parasites that occur normally in the skin and mucous membranes. these can cause serious disease if they invade the deeper tissues. we are also exposed to highly infectious bacteria that can cause acute lethal diseases such as pneumonia and typhoid fever. white blood cells form a special system for combating the different infectious and toxic agents: (1) by actually destroying invading agents by phagocytosis, and (2) by forming antibodies and sensitized lymphocytes to destroy the invader. the real value of white blood cells is that most are specifically transported to areas of infection, thereby providing a rapid and potent defense against infectious agents. this chapter is concerned with the normal structure and function of white blood cells and how they are formed in the body."
    },
    {
        "page": 74,
        "text": "cells 9% ait chapter vii. white blood = calls) a white blood cells or leukocytes (\\eukos = white, cytes because they are true cells that do not contain the red oratein, hemog}alit normal count. the average total leukocytic count is 40-10,0 / mm* blood. histologically, wbcs are classified into: 4- granular leukocytes (granulocytes) which have specific granules in their cytoplasm. these are further subdivided according to the staining affinity of their granules into: - neutrophils, - eosinophils, - basophils. 2- agranular leukocytes (agranulocytes) which lack specific granules in their cytoplasm. they include: - monocytes, - lymphocytes. unlike the erythrocytes, leukocytes do not function within the bloodstream. they travel in the blood from one region to another, then they leave the bloodstream by migrating between the endothelial cells to enter the connective tissue and perform their function. vii-a. granular leukocytes neutrophils they are so called because their cytoplasmic granules have a neutral staining affinity to the stains in blood film. neutrophils are also called polymorphonuclear leukocytes (pnls) because of the variability of their nuclear shapes. young, mature cells are bilobed while older cells may show up to 5 nuclear lobes. normal differential count: they constitute 60-70% of the total leukocytic count. lm picture (figure 39) in blood film: they have lightly- stained cytoplasm. nucleus: mul/tilobed formed of 2-5 segments that are interconnected with a thin chromatin thread. in females with a normal karyotyping (44+xx - chromosomes), one of the x-chromosomes is condensed and attached to the nucleus forming a drumstick appendage known as the barr body. 72"
    },
    {
        "page": 75,
        "text": "chapter vii. white blood cells em picture shape: during phagocytosis, pnls have an irregular outline due to extension of pseudopodia. the cytoplasm contains two types of granules: - small specific granules containing various protease enzymes e.g. collagenase that help neutrophils to perform their phagocytic function. - larger azurophilic granules containing lysosomal hydrolytic enzymes and the antibacterial defensins. figure 39. neutrophil function of neutrophils pnls are the first /ine of defense against any invading micro-organism as they leave the circulation and migrate to the site of action in connective tissue. they are called microphages, they recognize and engulf small particles as bacteria and destroy them using the contents of their granules. during the inflammatory reaction, neutrophils themselves are damaged by the bacterial toxins and by the products of the different inflammatory cells causing their death and they are called pus cells. eosinophils they are so called because they have a strong affinity to the eosin component of the stains in blood film. normal differential count: they constitute about 1-4% of the total leukocytic count. lm picture (figure 40) nucleus: dense, bilobed, c-shaped. 03."
    },
    {
        "page": 76,
        "text": "chapter vii. white blood cells cytoplasm: contains large, shiny reddish granules. em picture the cytoplasm contains two types of granules: large specific granules with electron dense crystalloid core and containing major basic protein and histaminase enzyme. small azurophilic granules containing lysosomal hydrolytic enzymes. figure 40. eosinophil function of eosinophils - they migrate to the connective tissue particularly under the mucosa of the digestive, respiratory and genito-urinary tracts as well as in the skin. - eosinophils are activated in parasitic infections. they are not phagocytic cells. the proteins in their specific granules act on the surface of the parasitic worm, forming pores in it, thus facilitating access of other lethal substances in the granules, to the parasite causing its death. - they are responsible for down-regulation of allergic immune reactions by the histaminase enzyme. basophils they are so called because of their strong affinity to the basic component of the stains in blood film. basophils are also called mast cells of the blood; because they secrete heparin and histamine like the connective tissue mast cells. 74"
    },
    {
        "page": 77,
        "text": "chapter vii. white blood cells normal differential count: they are the least numerous leukocytes, constituting about2- 1 % of the total leukocytic count. lm picture (figure 417) nucleus: bilobed, s-shaped. the nucleus is obscured by the abundant basophilic cytoplasmic granules in the cytoplasm. when stained with toluidine blue, basophils demonstrate a metachromatic staining property where the granules appear red instead of blue because of their content of heparin (sulphated glycosaminoglycans). figure 41. basophil em picture the cytoplasm contains two types of granules: a- large specific granules containing heparin and histamine. b- small azurophilic granules containing lysosomal enzymes function of basophils basophils are similar to mast cells; they are involved in hypersensitivity reactions. release of histamine causes vasodilatation, oedema, bronchospasm and skin rash. sudden release of large amounts of histamine from the granules might lead to a generalized fatal allergic reaction (anaphylaxis). 75"
    },
    {
        "page": 78,
        "text": "chapter vii. white blood cells vii-b. agranular leukocytes monocytes they are so called because they have a single, non-segmented nucleus. normal differential count: they constitute about 3-8 % of the total leukocytic count. lm picture (figure 42) - inblood film: monocytes are the /argestleukocytes. - nucleus: large, eccentric and kidney- shaped or horse-shoe shaped with deep indentations. - cytoplasm: abundant, pale basophilic and finely granular. em picture - shape: during phagocytosis, monocytes have an irregular outline due to extension of pseudopodia. - cytoplasm: contains small dense azurophilic granules containing lysosomal hydrolytic enzymes. monocyte figure 42. monocyte function of monocytes monocytes stay in circulation for only a few days, they then migrate to the different body tissues. there, they can differentiate to specific tissue macrophages that constitute the mononuclear phagocytic system that include: 76"
    },
    {
        "page": 79,
        "text": "chapter vii. white blood cells - macrophages in connective tissue - osteoclasts in bone, - microgliain cns, - von kupffer cells in the liver, - in chronic infections, macrophages fuse with one another, forming multinucleated giant cells. macrophages play an important immunologic role by: 1- phagocytosis of foreign substances (antigens) e.g. bacteria, virus- infected cells, malignant cells. 2- acting as antigen-presenting cells; after phagocytosis they can process antigens and present them to t lymphocytes. vii-c. granulopoiesis it is the formation of granular leukocytes, including neutrophils, eosinophils and basophils, in the bone marrow. granulopoiesis passes through the following common stages: 1. phscs. 2. mhscs. 3. colony forming unit- granulocyte, erythrocyte, monocyte, megakaryocyte (cfu- gemm). further differentiation of colony forming units ends with the formation of neutrophils by (cfu-g), eosinophils (cfu eo), basophils (cfu -ba) and monocytes (cfu-m). 4. myeloblasts. 5. promyelocytes: the cytoplasm of these cells is more basophilic as active protein synthesis goes on and the production of azurophilic granules begins. 6. myelocytes: at this level, the specific granules for each type of the granulocytes start to appear in addition to the azurophilic granules. accordingly, the cytoplasm shows decreased basophilia and increased eosinophilia in neutrophils and eosinophils; whereas basophilia dominates in basophils. the cells after this stage do not undergo further cell division but proceed with their morphological maturation. 7. metamyelocytes: e_t"
    },
    {
        "page": 80,
        "text": "chapter vii. white blood cells the specific granules are more abundant. the cytoplasm shows the staining affinity characteristic for each of the granular leukocytes. the neutrophils, in particular, present by the end of these stage with an additional phase known as the band cells. they are immature neutrophils with a characteristic band-shaped nucleus. they are usually retained in the bone marrow as a store to be released into the circulation whenever there is an acute infection. 8. mature granulocytes: in addition to the full development of the specific and the azurophilic granules, the nucleus becomes segmented in the pattern characteristic for each type of the granulocytes. lymphocytes lymphocytes are so called because they constitute the main cell population in the different /ymphoid organs. only a small fraction of lymphocytes is circulating in blood. normal differential count: they constitute about 20-30 %of the total leukocytic count. life spam. \\ymphocytes can live for several months. the memory cells (one type of lymphocytes) can live for several years. lm picture (figure 43) shape& size: rounded cells with variable diameter. nucleus: large, dense and slightly indented. cytoplasm: narrow rim of basophilic cytoplasm which surrounds the nucleus. | figure 43. lymphocyte 78"
    },
    {
        "page": 81,
        "text": "chapter vii. white blood cells em picture - cytoplasm: contains small dense azurophilic granules containing lysosomal enzymes. - the cell coat. contains a large number of cell surface receptors acting as antigenic markers. these include the c/uster of differentiation antigens. - on the basis of these surface receptors, lymphocytes can be classified into the different functional types. types and functions of lymphocytes they are divided according to their s/ze into: 1- large lymphocytes. 2- medium-sized lymphocytes. both the large and medium-sized lymphocytes are functionally- less differentiated lymphocytes. 3- small lymphocytes. most lymphocytes in blood are small with a diameter similar to that of rbcs. they represent the mature form of lymphocytes. lymphocytes are functionally further subdivided into: - t lymphocytes: they constitute 60-80% of small lymphocytes. they develop in bone marrow and mature in the thymus (hence the initial letter t). they are responsible for ce//- mediated immune response. - b lymphocytes: constitute 20-30% of small lymphocytes. they develop and mature in the bone marrow. they are responsible for the aumoral immune response. - natural killer (nk) cells: these cells lack the marker molecules characteristic of t and b cells. they originate from the same precursors of t and b cells in bone marrow. they are larger than t and b lymphocyctes with cytoplasmic granules. vii-d. lymphopoiesis _ it is the formation of lymphocytes. it takes place in the primary lymphoid organs (bone marrow and thymus). it passes through the following stages (figure 44): 1. phscs. 2. mhscs. 3. colony forming unit- lymphocyte (cfu- ly) some daughters of these cells migrate during fetal and early postnatal life to the cortex of the thymus where they differentiate into colony forming unit- t lymphocyte (cfu-lyt).the rest remains in the bone marrow and 79"
    },
    {
        "page": 82,
        "text": "chapter vii. white blood cells differentiate to colony forming unit- b lymphocyte (cfu-lyb). both these colony forming units do not express specific surface receptor i.e. they are not /mmunocompetent. 4. colony forming unit- t lymphocyte (cfu-lyt): they undergo several cell divisions during their residence in the outer zone of the thymic cortex giving rise to t lymphoblasts. t lymphoblasts also divide repeatedly producing immunocompetent t lymphocytes expressing specific surface receptors. 5. colony forming unit- b lymphocyte (cfu-lyb): while still in the bone marrow, these cells divide giving rise to b lymphoblasts. they divide repeatedly producing immunocompetent b lymphocytes expressing specific surface receptors. pre-nk cell nk cell peripheral lymphoid organs c @) nk cell cfu-ly j opvry t ' bm thymus t cell & ry a functional types crv b cell & @2 | ) plasma cell b cell figure 44. formation and differentiation of lymphocytes 80"
    },
    {
        "page": 83,
        "text": "chapter viti. the immune system after studying this chapter the student should be able to: 1- 2. 3- 4- 5. 6- identify the types of immune response. list and describe the structure and function of cells involved in the immune response. describe how chemotaxis, diapedesis, degranulation and other properties of neutrophil- macrophages facilitate their defense function. describe the tissue macrophage system. describe structure of immunoglobulins. discuss different types of immunoglobulins. the immune system is responsible not just for defending the body against infection, but also against cancer. unfortunately, an active immune system also increases the risk of rejection following organ transplants, and therefore immunosuppressive drugs often have to be administered to prevent rejection. this chapter describes the components of the normal immune system and how they operate."
    },
    {
        "page": 84,
        "text": "chapter vi. the immune system vi-a. types of body defense mechanisms the function of the immune system is to protect the body from invasion and damage by different antigens, which can be microorganisms (bacteria, viruses or fungi), toxins and malignant cells. there are three main lines of defense mechanisms: 1-surface protective mechanisms in human, these provide the first line of defense. they include: a. the skin constitutes a relatively impenetrable barrier to most micro- organisms. b. the mucous surfaces of the body as the conjunctiva and oral cavity are protected by antibacterial substances including the enzyme lysozyme which is secreted in tears and saliva. c. the ciliated respiratory epithelium is protected by a layer of surface mucus which is continuously removed with the trapped particles. d. the maintenance of an acidic environment in the stomach and vagina inhibits the growth of pathogens in these sites. when such defenses fail, the two other types of defense mechanisms are activated. 2-non-specific immune response (innate immune system) invasion of tissues by micro-organisms usually triggers a non-specific response called acute inflammation in order to remove dead tissues or foreign body. this type of immune response includes: - the complement system that mediates a wide range of inflammatory processes. - the phagocytic cells (tissue macrophage system). - natural killer (nk) cells. 3-specific immune response this depends on the recognition of specific antigens. normally, cells of the immune system have the ability to distinguish self from non-self. there are two different but related types of specific immune responses; the ce// mediated immune response and humoral immune response. 82"
    },
    {
        "page": 85,
        "text": "chapter vi. the immune system vi-b. cells of the immune system cells of the immune system are: - lymphocytes. - macrophages and antigen presenting cells. - mastcells. - granulocytes (neutrophils, eosinophils, basophils). lymphocytes morphologically, all \\ymphocytes are similar in either light or electron microscope. they can be distinguished into 3 different types by immunohistochemical methods as each type exhibits specific surface markers or surface receptors. 1- t lymphocytes these originate in the bone marrow and migrate to the thymus where they proliferate, mature and acquire 7 ce// receptors (tcr) on their surface specific for certain antigen recognition. t cells subsequently migrate to the peripheral lymphoid tissues (lymph nodes, spleen and peyers patches in the ileum) where they come into contact with the antigens. when they are activated by the specific antigen, they proliferate and differentiate into four functional subtypes of t cells (cell- mediated immune response), these are : - cytotoxic t cells: they are known as killer cells. they specifically recognize foreign cells and destroy them by release of perforins and granzymes. perforins create holes in the membrane of the target cells with subsequent cell lysis, while granzymes induce apoptosis and death of the target cells. - t helper cells: they produce /ymphokines capable of inducing proliferation and differentiation of b and t lymphocytes. - tregulatory (suppressor cells): they decrease the activities of other t and b lymphocytes. - tmemory cells: \\ong- lived cells responding more rapidly and strongly upon subsequent exposure to the same antigen. 2- b-lymphocytes these originate in the bone marrow where they proliferate, mature and acquire surface membrane immunoglobulins (slgs) receptors specific for certain antigen recognition. b cells subsequently migrate to the peripheral 83"
    },
    {
        "page": 86,
        "text": "chapter vi. the immune system lymphoid tissues where they come into contact with antigens. when they are activated by the specific antigen, they proliferate and differentiate into: - plasma cells. secrete large amounts of antibodies (humoral immune response). - bmemory cells: \\ong- lived cells responding more rapidly and strongly upon subsequent exposure to the same antigen. 3- natural killer cells (nk lymphocyte) they lack the surface markers characteristic of b and t cells. they act non - specifically to kill virally- infected cells and malignant cells., by the context of their granules antigen presenting cells (apcs): they originate from the bone marrow and are found in most tissues. they interact with t lymphocytes to stimulate the immune response. they include: - macrophages. - langerhans cells of the skin and oral cavity. - blymphocytes. - epithelial reticular cells of the thymus. neutrophils and monocyte macrophages neutrophils are mature cells that can attack and destroy foreign agents even in the circulating blood (microphages). in contrast, blood monocytes are immature cells that have very little ability to fight infectious agents. however, once monocytes enter the tissues, they begin to swell and numerous lysosomes develop in the cytoplasm, giving it the appearance of a bag filled with granules. these cells are now called macrophages,and are extremely capable of combating disease agents inside the tissues. defensive properties of neutrophils and monocyte-macrophages neutrophils and monocyte-macrophages have special properties that help them perform their defense function. these properties include: 1.chemotaxis invasion of the body by bacteria triggers the inflammatory response. many different chemical substances in the tissues cause both neutrophils and monocytes to move towards the source of the chemicals. this phenomenon is known as chemotaxis. chemotactic substances include: a) some of the bacterial toxins. b) degenerative products of inflamed tissues. c) several reaction products of the complement system. 84"
    },
    {
        "page": 87,
        "text": "chapter vii. the immune system 2. diapedesis it is the process by which neutrophils and monocytes can squeeze through the pores of the blood vessels to reach the inflamed area (figure 45). 3. ameboid motion both neutrophils and monocytes move through the tissues by ameboid movements to reach the site of inflammation. diapedsis increased : permeability chemotactic substance margination figure 45. chemotaxis and diapedesis 4. phagocytosis and degranulation after reaching the site of inflammation, neutrophils and monocytes perform their most important function which is phagocytosis: this means ingestion of the invading organism by endocytosis (phagocytosis). neutrophil granules discharge their contents into the phagocytic vacuoles containing the bacteria and also into the interstitial space (degranulation). the granules contain various proteases plus antimicrobial proteins called defensins. in addition, the cell membrane-bound enzyme nadph oxidase is activated, with the production of toxic oxygen metabolites. the combination of the toxic oxygen metabolites and the proteolytic enzymes from the granules makes the neutrophil a very effective killing machine. activated monocytes engulf and kill bacteria by processes generally similar to those occurring in neutrophils. 85"
    },
    {
        "page": 88,
        "text": "chapter vi. the immune system rough surface, loss of protective coat and recognizing of the foreign material increase phagocytosis. the immune system develops antibodies against infectious agents. these antibodies then adhere to the bacterial cell membrane and thereby make the bacteria susceptible to phagocytosis. these antibodies are called opsonins and the entire process is called opsonization. the tissue macrophage system (reticulo-endothelial system) it is a generalized phagocytic system located in all tissues, but especially in those tissue areas where large amounts of particles, toxins and other unwanted substances must be destroyed such as the liver and spleen. vi-c. immunoglobulins figure 46. electrophoretic pattern of serum proteins basic structure of immunoglobulins the basic structure is the same for all classes: e immunoglobulin molecule is y-shaped and composed of 4 polypeptide chains: 2 identical light chains (l) and 2 identical heavy chains (h), linked by disulphide bonds. 86"
    },
    {
        "page": 89,
        "text": "chapter vii the immune system both l and h chains have variable regions (v, & v,,) amino terminal part and constant regions (c, & c,,) carboxy terminal part. the variable regions have variable amino acid sequence and form the antigen binding site of the immunoglobulin. each immunoglobulin has two identical antigen-binding sites. the constant region has almost constant amino acid sequence in all immunoglobulins of the same class. immunoglobulins are glycoproteins containing carbohydrate groups attached to the constant regions of the heavy chains. a | antigen- binding site figure 47. basic structure of igg molecules light chains have lower molecular weight (32 kda) and are approximately 2 the length of h-chains. the v_ region is the amino terminal %, while the c, region is the carboxy terminal % of l-chain. e according to the structure of c, region, there are 2 types of light chains: kappa (a) and lambda (1). a given immunoglobulin molecule contains two kor two / chains, the a chains are more common. heavy chains have higher molecular weight (50 - 70 kda). the v,, region is the amino terminal %, while c,, region is the carboxy terminal % of h-chain. the structure of c,, region determines the class and subclass of immunoglobulin: there are 5 types of heavy chains: and // ; which determine the classes of immunoglobulins, which are: iga, igg, igd, ige and igm respectively. 87"
    },
    {
        "page": 90,
        "text": "chapter vi. the immune system 4 a region t ls complement . : binding region constant region | of heavy chain 5 i { ; i crystallizable fragment fe figure 48. structure of the immunoglobulin classes of immunoglobulins there are five classes of immunoglobulin that differ in amino acid sequences in the constant region of the heavy chains. ig existence immuno- h- symbol subclasses globulin chain 1 | monomer igg 75% gamma y igg1, g2 | g,3 2 | in serum as iga 10-15% alpha a iga1, monomer a2 secretary is | dimmer 3 | pentamere igm 5-10% mu lad igm1 igm2 4 | monomer igd r 0.2% delta 2) - 5 | monomer ige v. low epsilon - conc. 88"
    },
    {
        "page": 91,
        "text": "chapter vi. the immune system functions of immunoglobulins 7- immunoglobulin g (lgg) (1) because of its low molecular weight, it can traverse blood vessels to tissues and can pass through the placenta to the fetus providing passive immunity for the newborn in the first 6 months after delivery. (2) it has antibacterial, antiviral, antiprotozoal and antitoxins activities. (3) it increases in the secondary immune response. (4) it fixes and activates complement (mainly classical pathway). 2- immunoglobulin a (iga, figure 49) monomer dimer j chain secretory component figure 49. structure of iga (1) provides immunity for the newborn (found in colostrum and milk). (2) responsible for local immunity at mucous membrane surfaces, which are the main entry sites of pathogens. (3) fixes and activates complement (alternative pathway). eas 5"
    },
    {
        "page": 92,
        "text": "chapter vii. the immune system 3- immunoglobulin m (igm) figure 50. structure of igm (1) igm is produced in the primary immune response. (2) it fixes and activates complement (classical pathway). (3) it gives agglutination reaction with antigen. 4- immunoglobulin e (ige) (1) ige mediates allergy (type | hypersensitive reaction): a- ige binds to receptors on tissue mast cells or blood basophils by its fo. b- antigen binds to this ige, leading to release of mediators as histamine, bradykinin and_ serotonin. histamine and bradykinin cause vasodilatation of small blood vessels of skin leading to urticaria. serotonin can cause vasoconstriction and bronchoconstriction leading to bronchial asthma. (2) ige protects against parasites by causing release of enzymes from basophils. 5- immunoglobulin d (lgd) - present on the surface of b-lymphocytes where it functions as a receptor for antigens. - antibodies against insulin and food toxins are found to be igd. 90"
    },
    {
        "page": 93,
        "text": "chapter ix. the lymphatic system after studying this chapter the student should be able to: 1- relate the histological structure and function of the main lymphoid organs (thymus, lymph node, spleen & palatine tonsils) to their clinical significance. myasthenia gravis is a serious and sometimes fatal disease in which skeletal muscles are weak and tire easily. it occurs in 25 to 125 of every 1 million people worldwide. it is caused by the formation of antibodies to muscle acetylcholine receptors. the thymus may play a role in the pathogenesis of the disease by supplying helper t cells that cross-react with acetylcholine receptors. in most patients, the thymus is hyperplastic. thymectomy induces remission in 35% of patients. this chapter gives an overview of normal structure and function of the th mus and other lymphoid organs."
    },
    {
        "page": 94,
        "text": "chapter ix. the lymphatic system the lymphatic system is closely- related to the immune system (figure 51). it consists of: adenoid tonsils fs ty thymus lymph node lymph vessel spleen peyers patches ; in small intestine appendix lymph node bone marrow figure 51. the lymphatic system - lymph: a protein- rich fluid collected from the intercellular spaces. - lymph vessels: irregular channels which carry the lymph. - lymphoid organs: they can be classified into: 1. primary (central) lymphoid organs: responsible for development and maturation of lymphocytes. they are the thymus and bone marrow. 2. secondary (peripheral) lymphoid tissues: provide the proper environment in which lymphoid cells can react with each other and with antigens to elicit an immunological response against the different antigens. they include: - lymph nodes. - spleen. - lymphoid nodules in the tonsils, peyers patches in the ileum and appendix. 92"
    },
    {
        "page": 95,
        "text": "chapter ix. the lymphatic system ix-a. the thymus the thymus is located in the superior mediastinum behind the sternum. it is active in childhood but it progressively atrophies from puberty to old age where most of the lymphoid tissue is replaced by adipose tissue. histological structure of the thymus /- stroma: the thymus is surrounded by a connective tissue capsule from which connective tissue septa (trabeculae) extend into the parenchyma and divide it into incomplete /obules. m- parenchyma: each lobule has a peripheral dark cortex and an inner pale medulla. cortex of thymic lobule (figure 52) cortical epithelial cell cortex thymocyte heed (bone marrow cortico pe dtp es origin) medullary pe moehat2 medullary junction : | ans epithelial cell medulla hassalls corpuscle x a. macrophage ow (bone marrow origin) figure 52. cells in the thymus - the cortex is darkly stained because of densely- packed cells. - the cortex is composed of: 1. an extensive population of thymocytes (developing t lymphocytes). . dispersed epithelial reticular cells. they provide a supporting framework (cytoreticulum) for the developing t lymphocytes. 3. macrophages. _ a 2"
    },
    {
        "page": 96,
        "text": "chapter ix. the lymphatic system medulla of thymic lobule - the medulla is pale because of its loosely- packed cells. - the medulla of adjacent lobules is connected together due to the incomplete lobulation of the gland. - the medulla contains: 1. asmall number of mature small lymphocytes. 2. few macrophages. 3. a large number of loosely- arranged epithelial reticular cells. they form the cytoreticulum of the medulla. 4. hassalls corpuscles: they are whorls of eosinophilic concentrically- arranged flattened epithelial reticular cells. in the central portion of the corpuscle the epithelial reticular cells are filled with keratohyaline granules and cytokeratin filaments and they may calcify. their function is still not fully understood. n.b: lymphoid nodules, b lymphocytes and plasma cells are lacking in the thymus. vascular supply and blood-thymus barrier (figure 53) - the only blood vessels supplying the cortex are looped capillaries that extend from the arterioles at the cortico- medullary junction. the blood-thymus barrier consists of 1 a & www nh 6. continuous (non-fenestrated) endothelial cells of the blood capillaries joined together by occluding junctions. . basal lamina of the endothelial cells. . the pericytes surrounding the capillary wall. . macrophages in the perivascular connective tissue. . basal lamina of the epithelial reticular cells. epithelial reticular cells joined together by occluding junctions. - function: this barrier prevents circulating foreign antigens from reaching the thymic cortex where t lymphocytes are still in state of education and proliferation. - the lymphocytes that reach maturity in the cortex then enter the circulation through the post- capillary venules present at the cortico- medullary junction. - mature t cells then migrate, home and become activated in thymus- dependent areas of secondary lymphoid organs. 94"
    },
    {
        "page": 97,
        "text": "chapter ix. the lymphatic system a - the epithelial reticular cells of the thymus produce several growth factors that stimulate t cell proliferation and differentiation e.g. thymopoietin. epithelial reticular cell layer blood- perivascular developing t cells figure 53. the blood-thymus barrier ix-b. lymph nodes these are kidney- shaped bodies, which fi/ter the lymph. they are located along the course of the lymphatic vessels. the lymph node is indented at the hilum where arteries enter while veins and efferent lymphatic vessels leave the lymph node. in cut section, the lymph node consists of an oufer dense cortex and an inner pale medulla. histological structure of lymph node (figure 54) 1-stroma - the lymph node is surrounded by a fibroelastic capsule that sends many perpendicular septa (trabeculae) that divide the cortex into several 95"
    },
    {
        "page": 98,
        "text": "chapter ix. the lymphatic system compartments. on reaching the medulla, these trabeculae run in different directions, anastomosing with each other. - reticular connective tissue network supporting the parenchymal cells and the lymph sinuses in its meshes. cortex deep cortex capsule figure 54. structure of the lymph node 2- parenchyma a. cortex; it can be divided into two regions: 71. outer cortex: it is situated under the capsule. it consists of the cortical lymphoid nodules separated by the cortical lymph sinuses. the cortical nodules are rounded or oval dense lymphoid nodules formed by b lymphocytes and macrophages. when the lymph node is activated by lymph- borne antigens the b lymphocytes at the center of the nodule develop into larger, less closely- packed /ymphobilasts forming pale central areas called germinal centers. the result of germinal center formation is the production of an expanded population of b memory cells and plasma cells. the cortical lymphoid nodules are either primary (without germinal center) or secondary (with germinal center). 2. inner cortex (thymus- dependent zone) or the paracortical area: it consists mainly of t lymphocytes which are not arranged as nodules. 96"
    },
    {
        "page": 99,
        "text": "chapter ix. the lymphatic system b. medulla: - the dense lymphoid tissue in the medulla is in the form of wavy columns of cells, the medullary cords. - they branch and anastomose and are separated by medullary lymph sinuses. - the medullary cords are formed of densely- packed b lymphocytes, plasma cells and macrophages. they have no germinal centers. c. the loose lymphoid tissue: it is formed of loosely scattered lymphocytes, plasma cells and macrophages with lymph sinuses surrounding the dense cortical lymphoid nodules and medullary cords. ~~ afferent lymph vessel _ lymphoid nodule _ capsule > subcapsular sinus paracortex medulla _-~en medullary sirus * lymph = arterial blood s lymph venous blood , a artery \\. efferent lymphatic . vessels vein < subcapsular sinus ~~ |posteapillary venules ~~ capillary bed . mm a trabecular sinus trabecula figure 55. circulation in the lymph node lymph circulation in the lymph node (figure 55) 1. many afferent lymphatic vessels cross the capsule and pour lymph into the subcapsular sinuses. lymph is drained to the cortical sinuses then into the medullary sinuses. the medullary sinuses converge towards the hilum where they drain the filtered lymph into the efferent lymphatic vessels. 97"
    },
    {
        "page": 100,
        "text": "chapter ix. the lymphatic system -c. the spleen the spleen is the largest lymphoid organ in the body. its function is to filter the blood. histologically, the spleen is formed of stroma and parenchyma. histological structure of the spleen (figure 56) 7- stroma: e the spleen is surrounded by a thin capsule covered by peritoneum (mesothelial cells). e atthe hilum, the capsule is thickened and sends trabeculae that run in the splenic parenchyma in different directions carrying along them the blood vessels. e the capsule and the trabeculae consist of collagen, elastic and numerous smooth muscle fibers. e reticular connective tissue network supporting the parenchymal cells and the blood sinusoids in its meshes. it is denser in the white pulp than in the red pulp. 2.- parenchyma: subdivided into white and red pulps. a. white pulp (the malpighian corpuscles): - itis formed of lymphoid nodules, scattered in the substance of the spleen. - these lymphoid nodules are traversed by the central artery or follicular artery which is always eccentric in position. - the areas around the central arteries are called periarterial lymphoid sheaths (pals) which are thymus-dependent areas consisting predominantly of t-lymphocytes. - the lymphoid nodules are formed mainly of b lymphocytes and macrophages. they may contain germinal centers formed of lymphoblasts and plasma cells which then migrate to the red pulp. b. the red pulp: - it is formed of a network of branching and anastomosing b/ood sinuses (splenic blood sinusoids) separated from each other by the splenic cords or billroths cords. 98"
    },
    {
        "page": 101,
        "text": "chapter ix. the lymphatic system splenic (germinal nodule | center. (white |marginal pulp) the splenic cords are ce//u/jar masses of varying thickness and shapes; consist of erythrocytes, macrophages, lymphocytes, plasma cells, and granulocytes. the blood sinuses of the spleen are characterized by the presence of slits between the endothelial cells, so worn out or defective erythrocytes and platelets are severely damaged when they pass through these slits and phagocytosed by the macrophages associated with the sinusoidal walls. splenic cords (red pulp) area venous sinuses trabecular } and vein artery figure 56. the spleen c. the marginal zone: it is the area around the margins of the lymphoid nodules between the red and white pulps. it is important because it is the site where: e the circulating t & b lymphocytes enter into their specific location in the splenic parenchyma. e blood- borne antigens have their first access to the parenchyma of the spleen thus initiate the immune response and are attacked by the splenic macrophages. 99"
    },
    {
        "page": 102,
        "text": "chapter ix. the lymphatic system ix -d. the tonsils tonsils are organs composed of aggregations of incompletely- encapsulated lymphoid tissue. they form a ring surrounding the pharynx that lie beneath the epithelium at the beginning of the digestive and the respiratory tracts. tonsils are reactive against mucosal antigens. they include; the palatine tonsils, the pharyngeal tonsil and the /ingual tonsils. the palatine tonsils (figure 57) the two palatine tonsils are located in the lateral walls of the oropharynx. each tonsil is characterized by: the anterior and medial surfaces of the tonsil are covered by non- keratinized stratified squamous epithelium which dips inside the parenchyma to form primary and secondary crypts. during infection, the lumen of the crypts may contain desquamated epithelial cells, lymphocytes, bacteria and pus cells. lymphoid nodules (primary and secondary) are present beneath the epithelium and around the crypts. loose lymphoid tissue is present in between the lymphoid nodules. it consists of loosely- arranged lymphocytes, plasma cells, macrophages and neutrophils. no lymph or blood sinuses are present. the lateral and posterior surfaces are covered by a connective tissue capsule which separate the tonsil from adjacent organs and acts as a barrier against spreading of tonsillar infections in follicular tonsillitis. a number of mucous acini are present within the connective tissue capsule. stratified squamous epithelium of the the oral cavity figure 57. the palatine tonsil 100"
    },
    {
        "page": 103,
        "text": "practice questions below are examples of the types of questions that you may meet in the exam- use them to familiarize yourself with different question styles. to answer the questions below you need to have studied chapters il, ill, iv and vi. (a) a 52-year-old man presents at the emergency department with chest pain. he is found to have a thrombus in his coronary artery. the doctor prescribes a vitamin k antagonist to inhibit coagulation factor synthesis. a thrombolytic agent is given to help break the thrombus. mcqs: choose the correct answer 1- which of the following does the thrombolytic agent activate? a. heparin b. plasminogen c. thrombin d. prothrombin 2- vitamin k is a cofactor for which of the following reactions in coagulation factor synthesis? a. methylation of serine residues b. glycosylation of lysine residues c. gamma carboxylation of glutamate residues d. oxidative phosphorylation 3- in the opposite diagram of a platelet, which of the following numbers refers to the factors responsible for this clinical condition? a.7 b.4 c.9 d.3 101"
    },
    {
        "page": 104,
        "text": "practice questions e essay questions 1. correlate the structure of blood platelets to their functions regarding platelet aggregation, maintenance of discoid shape , motility and clot retraction. 2. discuss the physiologic factors that normally prevent clotting in a non- injured blood vessel. 3. enumerate the sources of vitamin k. (b) a 60-year old lady complains of tiredness and shortness of breath. on examination, she is pale. after laboratory investigation she is diagnosed with iron-deficiency anemia. mcqs: choose the correct answer 1- the red blood cells in her blood film are likely to be: a. megaloblastic b. normocytic c. microcytic d. hemolytic 2- damage of the rbcs during passage in narrow capillaries is due to a defect in: a. actin & myosin b. myosin & spectrin c. microtubules & ankyrin d. actin & spectrin 3- the storage form of iron in the body is: a. transferrin b. ceruloplasmin c. ferritin d. ferroportin essay questions 1. enumerate the iron containing compounds in the body. 2. besides iron, name 2 other nutrients necessary to prevent anemia, and mention their role in erythropoiesis. 3. list the stages of erythropoiesis. name the cell where the synthesis of hemoglobin is completed and describe its histological structure. 102"
    },
    {
        "page": 105,
        "text": "chapter x. carbohydrate metabolism carbohydrate metabolism after studying this chapter the student should be able to: energy production glucose oxidation - 1- glycolysis e describe: name, function, substrates, products, control enzyme, regulation, compartment. e describe &calculateenergy production from carbohydrates through glycolysis. e compare the energy produced from glucose during anaerobic glycolysis with the energy produced in the conversion of glucose to pyruvate during aerobic glycolysis. energy production glucose oxidation - 2- glycolysis & cac e explain the cori cycle - describe lactic acidosis e describe cac : name, function, substrates, products, control enzyme, regulation, compartment. energy production glucose oxidation -3- cac e describe & calculate energy production from carbohydrates through citric acid cycle. glucose oxidation - hms e describe carbohydrates oxidation through alternative pathways, without energy production through the pentose phosphate pathway: function, substrates, products, control enzyme, regulation, and compartment. e importance of hms & glycolysis in rbc metabolism gluconeogenesis e describe the pathway for new glucose formation : name, function, substrates, products, control enzyme, regulation, compartment . uronic acid pathway& glycogen synthesis e describe glucose oxidation without energy production through an alternative pathway; uronic acid pathway: name, function, substrates, products, control enzyme, regulation, compartment . glycogen degradation and - metabolism of fructose&galactose e describe the pathway for glycogen degradation to glucose or glucose-6-phosphate in liver and muscle: name, function, substrates, products, control enzyme, regulation, compartment. e describe the pathway for metabolism of fructose & galactose & understand how enzymes will be controlled, & regulated in cellular compartments. 103"
    },
    {
        "page": 106,
        "text": "chapter x. carbohydrate metabolism fates of the absorbed monosaccharides : glucose, fructose, galactose and other monosaccharides are absorbed through portal blood to the liver. fructose is either oxidized or converted to glucose in the liver, while galactose is converted to glucose. the only sugar circulates in blood is glucose. part of this glucose is used in the liver to be stored as glycogen, oxidized or used in lipid synthesis. another part passes through systemic circulation to maintain blood glucose level (the fasting blood glucose level 70 - 110 mg/dl). glucose is used intracellular in: |. oxidation: the pathways for oxidation of glucose are: a. major pathways; which are mainly for energy production: 1. glycolysis, followed by oxidative decarboxylation of pyruvate and citric acid cycle (cac). b. minor pathways; which are not for energy production: 1. | hexose monophosphate shunt (hms). 2. uronic acid pathway. 11. conversion to biologically active substances as: 1. galactose: this is essential for formation of lactose, glycolipids, mucopolysaccharides, etc. 2. fructose: needed for nutrition of sperms. 3. amino sugars. 4. non-essential amino acids. 5. fatty acids. 6. ribose-5-p. 7. glucuronic acid. lii.storage of glucose as: 1. glycogen in the liver and muscles mainly. 2. triglycerides (tg), mainly in adipose tissues. excretion of glucose in urine: when blood glucose level exceeds renal sugar threshold (180 mg/dl), it passes to urine. this is known as glucosuria. 104"
    },
    {
        "page": 107,
        "text": "chapter x. carbohydrate metabolism glycolysis (embden meyerhof pathway) definition: it is degradation of glucose to generate atp and to provide intermediates for other synthetic and metabolic pathways. aerobically it ends with pyruvate while anaerobically lactate is the end product. site of glycolysis: it occurs in the cell cytosol of all tissues. it is the principle route for glucose metabolism and the main pathway for the metabolism of fructose and other carbohydrates derived from the diet. steps of glycolysis e conversion of glucose to g-6-p by hexokinase or glucokinase. hexokinase glucokinase | *site: ~<<~*=;*;:cs*y civil tissues. | liver and) b-cells of pancreas | mainly. *substrate: mainly glucose. | only glucose *affinity to high (low km) low (high km) glucose: *g-6-p: allosteric no effect. inhibitor *insulin: no effect. inducer. *glucagon: no effect. repressor. 1 055."
    },
    {
        "page": 108,
        "text": "chapter x. carbohydrate metabolism glycogen glucose 1- ; qhoh -_ who ch.-o- h h aa a h [rouen | | ox ce.0h 7 \\ hh oh i) h ho, oh h oh h a-b-glucose ; a onlucose 6-phosphate 0-fructose 6-phosphate atp : p-fructose 1,6-bisphosphate ch.-0 ~) on * lodoacetate ch,- o-p . t iglyceraldehy de-3-phosphate c =0- i dehydrogenase ch,0h i mg?* i h-c-oh a oh h- - ~o# atp = adp nadh+h*+ \\ ape romerase 1,3-bisphosphoglycerate glyceraldehyde 3-phosphate %0, mitochondrial h- c= 0 dihydroxyacetone phosphate 3-phosphoglycerate reapiatory chain \\ zz f) | coo ' ' 3adp = 3atp 2-phospho- i 1 +p, h- c- o-b qlycerate t ' ch.oh ; ' fluoride anaerobiosis mo\" p= h.0 ' i] i) 1 | coo ' c- o-~f) phosphoenolpyruvate i t t oxigen | ach cycle ' - adp . . pyruvate atp spontaneous \\ a ' ec - _ c- oh ho cc h ch, ca dehydrog senas e | ch, ({enol) (keto) pyruvate pyruvate l(+)-lactate es figure 58. steps of glycolysis 106"
    },
    {
        "page": 109,
        "text": "chapter x. carbohydrate metabolism importance of glycolysis: l-energy production: 1. under aerobic conditions: glucose > 2 pyruvate + 8 atp. for tissues that have mitochondria, glycolysis is considered a preparatory step for complete oxidation via citric acid cycle. the hydrogens of nadh produced by glycolysis are transported to the mitochondria to be oxidized by electron transport chain (etc). 2. under anaerobic conditions: glucose 2 lactate + 2 atp pyruvate is reduced to lactate in a reversible reaction catalyzed by lactate dehydrogenase (ldh). this reaction provides oxidized nad to insure the continuation of the pay off phase of glycolysis and production of the 4 atp molecules at the substrate level. this occurs in muscles during severe exercise, any hypoxic conditions and in tissues that lack mitochondria as rbcs and lens. a decrease in the amount of o2 will necessitate an increase in anaerobic glycolysis for energy production, leading to the generation of a large amount of lactic acid. lactic acid diffuses to the circulation and taken by: a. liver to enter the gluconeogenic pathway that provides glucose to the blood that patially compensate the high rate of anaerobic glucose oxidation. b. heart that converts lactate to pyruvate which is used for enegy production. c. kidney to be excreted in urine. cori cycle: lactate which is formed during anaerobic oxidation of glucose in muscles and in rbcs diffuses to the blood then to the liver. in the liver lactate is converted to glucose by gluconeogenesis. glucose goes back to tissues and is reutilized for production of energy. ma (7"
    },
    {
        "page": 110,
        "text": "chapter x. carbohydrate metabolism muscle: atp produced by glycolysis for rapid contraction lactate ae glycogen atp blood blood lactate glucose lactate ae glucose atp liver: atp used in synthesis of glucose (gluconeogenesis) during recovery figure 59. cori cycle ll-synthetic functions of glycolysis: 1. dihydroxyacetone phosphate can give glycerol-3-phosphate for synthesis of tag and phospholipids. 2. pyruvate acetyl coa >fa and sterols 3. synthesis of amino acids from intermediates of glycolysis. wl. importance of glycolysis in red cells: a) energy production: it is the only pathway that supplies the red cells with atp. since red cells are dependent on glycolysis for production of atp, some types of hemolytic anaemias are due to inherited deficiency of glycolytic enzymes mainly pyruvate kinase deficiency. b) reduction of methemoglobin: glycolysis provides nadh for reduction of met hb by nadh-cytbs-reductase enzyme. c) in red cells 1,3 bisphosphoglycerate is converted to 2,3 bisphosphoglycerate which binds to oxy hb decreasing its affinity to o2 and helps release of oxygen at tissues. 108"
    },
    {
        "page": 111,
        "text": "chapter x. carbohydrate metabolism regulation of glycolysis: the rate of glycolysis is regulated by the activity of the three irreversible enzymes; hexokinase, pfk, and pyruvate kinase. pfk is the main pacemaker, since it catalyzes the first irreversible reaction unique to the glycolytic pathway (the committed step). pfk is allosterically regulated by: energy state of the cell: it is inhibited by high levels of atp and activated by elevated levels of amp. availability of substrate : it is inhibited by high levels of citrate and activated by elevated levels of f-6-p. hormonal regulation of glycolysis: a) glucagon is secreted in hypoglycemia or in carbohydrate deficiency. it affects liver cells mainly as follows: 1- it acts as repressor of glycolytic key enzymes (glucokinase, pfk-1, pyruvate kinase). 2- it produces phosphorylation of specific enzymes leading to inactivation of glycolytic key enzymes. b) insulin: it is secreted in hyperglycemia and after carbohydrates feeding, it causes: 1- induction for synthesis of glycolytic key enzymes. 2- activation of glycolytic key enzymes. hormone (epinephrinen or glucagon ) via g protein(g -gtp) . _z insulin adentylate cyclase adenylate cyclase (inactive) (active) catalysis cyclic amp+pp so activation *\\ phosphodiesterase amp s) protein kinase a protein kinase a (inactive) (active) atp activation adp pfk-1 & pyruvate kinase active pfk-1 & pyruvate kinase inactive y p protein phosphate-1 figure 60. hormonal regulation of glycolysis aa qq"
    },
    {
        "page": 112,
        "text": "chapter x. carbohydrate metabolism regulation is achieved through hormones (induction or reperession of the regulated enzymes and covalent modification) and allosteric modifiers as shown in the table below. inducti | repressio | allosteric modifier covalent modification on n activator inhibitor phosphorylati | dephosphorylati & & on on inducer | repressor glucokinase _ insulin | glucagon hexokinase | constitutive _ g6p _ _ atp, pfk insulin | glucagon awe, i glucagon | insulin * fep tcitrate pk insulin | glucagon 4 f1,6p |#atp glucagon insulin inhibitors of glycolysis: 1. mercury and iodoacetate inhibit glyceraldehyde-3-p dehydrogenase by binding to a thiol (sh) group in its active site. 2. fluoride inhibits enolase by removal of mg as mg fluoride. n.b. arsenate is uncoupler of oxidation and phosphorylation, it forms 1- arseno-3-phosphoglycerate which interferes with atp formation at substrate level, but it does not prevent flux through glycolysis. arsenate competes for inorganic phosphate binding sites on enzymes, resulting in the formation of arsenate esters which are unstable. pyruvate metabolism some amino acids cghicase lactic acid eg ala. elycerol pyruvic acid g ss cmialic acid oral oacetic acid acetyl coa figure 61. sources and fates of pyruvate 110"
    },
    {
        "page": 113,
        "text": "chapter x. carbohydrate metabolism * pyruvate is transported to the mitochondria via a special pyruvate transporter where it can be transformed into acetyl co-a by oxidative decarboxylation catalyzed by a multi-enzyme complex known as pyruvate dehydrogenase complex. this reaction needs five cofactors which are: thiamine pyrophosphate (tpp or active vitamin b, ) , lipoic acid (l), coenzyme a (coash), fad and nad* coash co2 nad* adh+h* pyruvate dehydrogenase ch;-co-cooh pyruvic acid l, tpp ,fad acetyl coa figure 62. oxidative decarboxyiation * [t provides extra 6 molecules of atp formed by oxidation of 2 molecules nadh by the etc. * regulation of the activity of pyruvate dehydrogenase complex: 1. acetyl coa and nadh+h* (the products of oxidation of pyruvate), allosterically inhibit the enzyme complex. 2. covalent modification. the enzyme exists in active dephosphorylated form and it is inactive in phosphorylated form. n.b: *arsenite and mercury inhibit pyruvate dehydrogenase complex by reacting with the sulphydryl group of lipoic acid leading to accumulation of pyruvate and formation of lactic acid and lactic acidosis. 1"
    },
    {
        "page": 114,
        "text": "chapter x. carbohydrate metabolism citric acid cycle (cac) tricarboxylic acid cycle = krebs cycle definition: it is a series of reactions in mitochondria that brings about the catabolism of acetyl residues, liberating hydrogen equivalents which upon oxidation, leads to the release of energy. site and steps: > cac occurs only in cells containing mitochondria. > succinyl coa is formed by oxidative decarboxylation of @- ketoglutarate. this reaction is catalyzed by %-ketoglutarate dehydrogenase complex, consisting of three enzymes and needs 5 coenzymes ( nad*, coenzyme-a, fad, lipoic acid and tpp) > the succinyl coa has an energy rich bond. the cleavage of the thioester bond of succinyl coa is coupled to the phosphorylation of guanosine diphosphate (gdp) leading to the formation of succinate and gtp. this reversible reaction is catalyzed by thiokinase enzyme (succinyl coa synthetase). it is the only step in cac that yields a high energy phosphate bond directly. the y -phosphate group of gtp is readily transferred to adenosine diphosphate (adp) to form atp in a reaction catalyzed by nucleoside diphosphokinase (gtp + adp < gdp + atp). acetyl-coa citrate oxaloacetate lsocitrate citric a son acid ws cycle a-ketoglutarate furmarate f& _nadh | ot succinyl-coa 4 figure 63. citric acid cycle (cac) a 112"
    },
    {
        "page": 115,
        "text": "chapter x. carbohydrate metabolism h2o + pie h3c~ 00- _ h-c-oh re] coo- . aia 0oceh ch2 nad* nadh + ht coo- oxaloacetate isocitrate malate vig teccaindil nadh + h+ dehydrogenase : + co nad* y g 2 ooc. 2 00- i hoch k ch2 : malate | 00 coo- a-ketoglutarate fumarase w207 h.. -c00\" fumarate fadh; cts gdp + p; succinyl coa gtp ne coo- + coa succinate figure 63 b . citric acid cycle (cac) importance of cac: energy production: every one mole of acetyl- coa produces 12 moles of atp as follows: 3nadh,h* _ etc 9atp fadh2 etc 2atp adp + pi substrate level atp total - 42atp il. tis amphibolic pathway i.e. both catabolic and anabolic: a) catabolic functions: it is the final common metabolic pathway for oxidation of carbohydrates, fats and proteins, as they all supply acetyl coa. b) anabolic functions: the most important anabolic functions are: 113"
    },
    {
        "page": 116,
        "text": "chapter x. carbohydrate metabolism 1- synthesis of fatty acids and cholesterol: citrate in high concentration is transported to the cytosol and cleaved by atp-citarte lyase giving acetyl coa which is used for synthesis of fatty acid and cholesterol. 2- synthesis of non-essential amino acids: by transamination c- ketoglutarate is converted to glutamate and oxaloacetate is converted to aspartate. 3- oxaloacetate in the cytosol is converted to pep which is converted to glucose (gluconeogenesis). 4- heme synthesis: by providing succinyl coa. 5- malate gives pyruvate by malic enzyme in the cytosol, this reaction provides nadph needed for fatty acid and cholesterol synthesis. malate pyruvate + cq; talic bilaytce mad nadph h* 6- co. produced is used in many important reactions including different cozfixation reactions, purines and pyrimidines and urea synthesis and synthesis of h2co3/ bhcos; buffer system. regulation of cac: short-term regulation through: 4- citrate synthase is activated by high concentrations of acetyl coa and oxalacetate. cac is inhibited by high concentration of citrate and succinyl coa. 2- a-ketoglutarate dehydrogenase is inhibited by high concentration of succinyl coa. 3- high nadh*/ nad* and atp/ adp ratios are inhibors of citrate synthase, isocitrate dehydrogenase and a -ketoglutarate dehydrogenase, while increased adp stimulates the three enzymes. n.b. unlike pyruvate dehydrogenase, &-ketoglutarate dehydrogenase is not regulated by covalent modification . 114"
    },
    {
        "page": 117,
        "text": "chapter x. carbohydrate metabolism inhibitors of cac: 1- fluoroacetyl coa: it combines with oaa giving rise to fluorocitrate, which inhibits aconitase enzyme. 2-malonic acid inhibits succinic acid dehydrogenase (competitive inhibition). 3- arsenite and mercury inhibit pyruvate dehydrogenase and a- ketoglutarate dehydrogenase complex by reacting with sulphhydral group of lipoic acid, leading to accumulation of pyruvic, lactic and a- ketoglutaric acids with acidosis. total atp produced from complete oxidation of one molecule of glucose during glycolysis, oxidative decarboxylation and cac: @ glycolysis g _ 2pa + 8 atp m@ oxidative decarboxylation 2pa _> 2 acetyl coa + 6 atp (2 nadh + h* x3) m= cac 2 acetyl coa (12 atp x2) _- 24 atp m@ net _-_ 38 atp hexose monophosphate pathway (hmp) = pentose phosphate pathway (p) = phosphogluconate oxidative pathway = direct oxidation of glucose definition: it is an alternative route for the oxidation of glucose without direct consumption or generation of atp. site and steps: it is active in the cytosol of many cells e.g. liver, adipose tissue, rbcs, adrenal cortex, ovaries, testis, retina and lactating mammary gland. the pentose phosphate pathway occurs in two phases; oxidative and non- oxidative. l- oxidative phase: this phase is irreversible; glucose-6-phosphate is converted to ribulose- 5-phosphate with production of two molecules of nadph. 115"
    },
    {
        "page": 118,
        "text": "chapter x. carbohydrate metabolism ll- non-oxidative phase: this phase is reversible. it ends with fructose-6-phosphate and glyceraldehyde-3-p nonoxidative oxidative phase phase glucose 6-phosphate nadp*. 2 gsh reductase gssg fatty acids, 6-phosphogluconate + sterols, etc. nadp nadph reductive biosynthesis co, nadph precursors ribulose 5-phosphate ribose 5-phosphate nucleotides, coenzymes, dna, rna figure 64. hexose monophosphate pathway oxidative irreversible phase of hms: hy de ch,opo; ch,opo; ch,oh nadp*+ nadph ho f nadp+ nadph \" | hal hoch ne loon glucose 6-phosphate lactonase hcoh 6-phosphpgluconate 4 ton ho h dehydrogenase hq _\" dehydrogenase | h amma 2- ch,opo3 6-phosphoglucono- 6-phospho- ribulose lactone gluconate 5-phosphate 116 -"
    },
    {
        "page": 119,
        "text": "chapter x. carbohydrate metabolism importance of hmp 1- hmp is the only way of r-5-p production in our body, which is needed for nucleosides, nucleotides, nucleic acids and coenzymes biosynthesis. 2- it is the main generator of reduced coenzyme ii (nadph+h*) which is needed in reductive biosynthesis. 3- importance of hmp in red cells: red cells are liable for oxidative damage by h2o2 due to their role in oz transport. in rbcs, h2o2 causes both oxidation of iron in hemoglobin to form methemoglobin and lipid peroxidation. lipid peroxidation increases the cell membrane fragility. the major role of hmp in red cells, is the production of nadph, which protect these cells from oxidative damage by providing reduced glutathione for removal of h2o>2. glucose 6-phosphate dehydrogenase deficienct impairs the ability of an , erythrocyte to form nadph, resulting oxidant stress in hemolysis certain drugs erythrocyte infections fava beans 7 glucose 6-phosphate glutathione glutathione a dehydrogenase reductase peroxidase glycolytic } a pathway is 6-phospho- i gluconate regulation of the pentose phosphate pathway: the reaction catalyzed by g6p dehydrogenase is the rate limiting in the oxidative branch i.e. the control site. the most important regulatory factor is the level of nadp*. nadph accumulation produces feedback inhibition of glucose-6-phosphate dehyrogenase. synthesis of g6pd is induced during feeding and repressed during fasting. insulin, which is secreted in response to hyperglycemia, 117"
    },
    {
        "page": 120,
        "text": "chapter x. carbohydrate metabolism increases the rate of glucose oxidation by hmp. insulin induces the synthesis of g6pd and 6-phosphogluconate dehydrogenase. gluconeogenesis definition: synthesis of glucose (and/or glycogen) from non-carbohydrate precursors such as, lactate, glucogenic amino acids, glycerol and propionate liver glycogen can meet these needs for only 10-18 hours in the absence of dietary intake of cho. during prolonged fasting, hepatic glycogen stores are depleted and glucose is formed from, non- carbohydrate precursors. site: the major site of gluconeogenesis is the liver (90%); it can also occur in the cortex of the kidney (10%). it occurs mainly in the cytoplasm and partly in the mitochondria. steps: it is nearly the reversal of glycolysis except for the three irreversible kinases as follows:- glycolytic key enzymes gluconeogenic key enzymes 1 | glucokinase, glucose-6-phosphatase hexokinase 2 | phosphofructo kinase-1 fructose-1 ,6- bisphosphatase 3 | pyruvate kinase - pyruvate carboxylase - phosphoenolpyruvate carboxykinase |- dicarboxylic acid shuttle: it is a mechanism by which phosphoenol pyruvate is formed from pyruvate by the way of oxaloacetate (dicarboxylic acid). pyruvate is carboxylated to oxaloacetate by pyruvate carboxylase (see pyruvate metabolism). this enzyme is liver and kidney mitochondrial enzyme but not present in muscle. oxaloacetate formed is transported across mitochondrial membrane in the form of malate. malate is reoxidized to oxaloacetate by a nad- linked malate dehydrogenase in the cytosol."
    },
    {
        "page": 121,
        "text": "chapter x carbohydrate metabolism oxaloacetate is decarboxylated and phosphorylated to yield phosphoenol pyruvate. this reaction is catalyzed by phosphoenol pyruvate carboxykinase (pepck) in the cytosol.(rate limiting step) coo~ cytosol inner mitochondrion coo ] mitochendrial i hoch fnernbeeris ho [8 et [be ee atnio coo nnabt i el nad* gdp malate = set bh ot malate pep denyda caer denydrogenase ee al fic nadh + ht nadh + n* coo enn oxsloacetate oxaloarcetate cmy ea :; coo arnino acid amino acid aspartate aspartate aminotransferase aminotransferase a-keto acid ecketa acid 1 aspartate sess aapartate en hken : nath ch is cy bid e fel e007 laie i in cytosol , in miyochondria glucose glucose-6-phosphate a fructose-1,6-bisphosphate * enzymes from glycolysis 2 phosphoenolpyruvate amino acids - 2 oxaloacetate amino acids + 2 pyruvate lactate gluconeogenesis ll- conversion of pep to glucose: two molecules of pep are utilized by reversal of glycolysis to form fructose 1,6-bisphosphate. the latter is converted to f-6-p by fructose 1,6 bisphosphatase, present in liver and kidney then to g-6-p by phosphohexose isomerase. free glucose is formed by the action of glucose 6-phosphatase in the liver and kidney, while it is absent in muscles and adipose tissues, thus 119"
    },
    {
        "page": 122,
        "text": "chapter x. carbohydrate metabolism glucose cannot be formed by these organs. in muscles g-6-p can be converted to g-1-p then, to glycogen. the gluconeogenic substrates: 1. lactate: 6 high energy phosphate bonds are spent during synthesis of glucose from 2 molecules of pyruvate 2. glucogenic amino acids: all amino acids can give glucose except leucine (pure ketogenic).after 18 hours fasting, proteins are considered as one of the main sources of glucose. 3. glycerol: it is mobilized from adipose tissues. two molecules of glycerol are utilized for production of one molecule of glucose in liver and kidney in fasting or low cho diet. glycerol can not be utilized in adipose tissue which lacks glycerol kinase. ache adp fac-oh nady nadh+h* hy, f -oh o gh lhkina at h3-oh _ * hac -o- p) 3-p hosp hate hat-l -p | dehydrogenase glycerol glycerol 3 -p hosp hate dilydroxyacetone phosphate (dh ap} reversal of shrolysis . (hucose importance of gluconeogenesis: 1. maintenance of blood glucose: when carbohydrates are not available in sufficient amounts e.g. starvation, prolonged exercise and low carbohydrate diet, as glucose is energy source to: o, ** brain tissues (brain cannot metabolize fatty acids) <2 + renal medulla, testis and faetus. ** to muscle and rbcs during anaerobic oxidation. 2. removal of glycerol produced by lipolysis in adipose tissues. 3. removal of lactic acid of anaerobic oxidation in rbcs and contracting muscle, thus control acid-base balance and prevent metabolic acidosis. regulation of gluconeogenesis: glycolysis and gluconeogenesis are reciprocally controlled. 120"
    },
    {
        "page": 123,
        "text": "chapter x. carbohydrate metabolism long-term insulin, is a repressor for the synthesis of gluconeogenic 4 key enzymes, and at the same time it acts as an inducer of glycolytic key enzymes. so it inhibits gluconeogenesis. anti-insulin (glucagon, adrenaline and cortisol): are secreted during fasting, stress, and severe muscular exercise. they act as inducers for these enzymes. short-term 1- high levels of atp & citrate allosterically stimulate f1,6 bisphosphatase. 2- excess acetyl coa _ allosterically stimulates pyruvate carboxylase uronic acid pathway it is an alternative oxidative pathway for glucose that does not lead to the generation of atp. site: in liver cytoplasm, mainly. importance: udp glucuronic acid (the active form) is needed in: 4. conjugation to less polar compounds as bilirubin, steroids and some drugs making them more ho soluble (detoxicated). 2. synthesis of glycosaminoglycans (mucopolysaccharides) as heparin, hyaluronic acid,.etc. glucuronic acid synthesis glucose -6-p phospho- u dp-glycose glucomutase udp - glucose pynophosphorylase udp- glucose glucose -1 -p 2 nad + dehydrogenase glucuronides oo proteoglycans glycosaminoglycans conjuction l - ascorbate metin human udp -glucuronate glucuronate figure 65. glucuronic acid synthesis 121"
    },
    {
        "page": 124,
        "text": "chapter \\sit giycoge neraoul's glycogen metabolism includes: * glycogenesis. * glycogenolysis. glycogenesis it is the intracellular synthesis of glycogen from glucose. site and steps: the main site is the cytosol of liver and muscle cells. in the liver it forms 8-10% of its wet weight and in muscle it forms 1-2% of its wet weight. most other cells may store minute amounts fe) udp - glucose pyrophosphorylase j ch,oh hn h oi on | h \" 6 a [e) n oh h ll u u ll oh otr + of o fo f och es h oh o oo o~ oo h glucose -1-phosphate utp o on pp; fe) ch,oh hn a h oo 4 aj h oo n oh h 1 i oh biof es o h oh oo o- h h udp - glucose ton ont figure 66. synthesis of udp-glucose 122"
    },
    {
        "page": 125,
        "text": "chapter x. carbohydrate metabolism ch,oh ch,oh | 4 oo. h 0 0 ok 4h tl ] + ho o-p0o p o0 uridine | | udp-glucose glycogen (n residues) glycogen synthase oo ql cc nh po fm om f och; ain co) cco) h h + h h udp oh oh vopp | glycogen (n+ 1 residues) figure 67-a. synthesis of glycogen synthesis of glycogen from udpg requires the presence of two enzymes: glycogen synthase and branching enzyme. 1. glycogen synthase: this is the key enzyme for glycogen synthesis. it catalyzes the transfer of glucose units from udp-g to glycogen primer (an already existing chain of glucose molecules), so that c, of activated glucose of udp-g is linked to c, of terminal glucose unit in the glycogen primer (growing glycogen) by a 1, 4 glucosidic linkage. this process can be repeated and produces elongation of the branches up to a minimum of 11 glucose residues. this is immature glycogen. 2. branching enzyme: [amylo (1, 4 +1, 6 ) transglucosidase] it transfers parts of the elongated chain (minimum length 6 glucose residues) from one branch to be linked to the nearest chain by a 1,6 glucosidic linkage forming a new branching point. the new branches are elongated by glycogen synthase and the process is repeated. 123"
    },
    {
        "page": 126,
        "text": "chapter x. carbohydrate metabolism oho 1-+4- ghee bond o unlabeled glucose residue cho 1-6 glucosidic bond @ 6-labolod glucose residue siscoes now 1+8- band udp |udp i _ ea glycogen primer flongated branches formation of new of clycogen branches (hmature slycogen) figure 67-b. synthesis of glycogen importance: - liver glycogen functions as a glucose reserve for the maintenance of blood glucose concentration especially between meals. after 12-18 hours of fasting, liver glycogen is depleted. - muscle glycogen is present to serve as a fuel reserve for atp generation within the muscle itself only during contraction. muscle glycogen is depleted after prolonged exercise. regulation of glycogenesis: l- covalent modification by hormones: glycogen synthase is the key enzyme of glycogenesis.it is present in 2 forms: (1) active dephosphorylated form (a-form). insulin effect. (2) inactive phosphorylated form (b-form). glucagon effect in liver and epinephrine effect in liver and muscle . (revise these effects in glycolysis) il. allosteric regulation of glycogenesis: a) g-6-p: activates glycogen synthase. accumulation of g-6-p means that the cell is not in need for more oxidation and atp production. b) glycogen: inhibits glycogen synthase. 124"
    },
    {
        "page": 127,
        "text": "chapter x. carbohydrate metabolism glycogenolysis definition: it is intracellular breakdown of glycogen to form g-1-p which is converted to g-6-p. site and steps: its main site is the cytosol of liver and muscles. it is catalyzed by: glycogen phosphorylase and two other enzymes. 1.* glycogen phosphorylase: the step catalyzed by phosphorylase is the rate limiting in glycogenolysis. active glycogen phosphorylase in the presence of inorganic phosphates acts onthe a 1, 4-glucosidic linkages of the outer most (terminal branches) of glycogen molecules, (between c, of the terminal residue and c, of the adjacent one) leading to formation of successive molecules of g-1-p, removing one glucose unit ata time. the action of the enzyme stops when there are four glucose residues on either side of a 1 >6 branch. 2.* another enzyme: a1, 4 __a@1, 4 glucan transferase it transfers a trisaccharide unit from one branch to the other, exposing the 16 branch point. ho ho ho ho () . non. wen oh oi\\oh fo) oh o\\oh reducing: branch hi ih rls or porm oh oh oh oh s oh sg ogos 11 p, bye: iye glycogen chain > nem, iy be glycogen phosphorylase gin 1-phosphare suh de ho: fo] i oh -po; limit cdexarin oh | glucanutransterusc glucose 1-p + hoy, hoz__, = hoq_, o ay oh oh oj\\oh hi glucose oh oh oh sa remaining glycogen figure 68 glycogenolysis 128 a"
    },
    {
        "page": 128,
        "text": "chapter x. carbohydrate metabolism 3.* debranching enzyme: amylo 1,6 -glucosidase: catalyzes the removal of the last glucose residue at the branching point by adding h2o producing free glucose, leaving a chain for further phosphorolysis by the phosphorylase enzyme. g-1-p formed by phosphorolytic cleavage of glycogen is converted into g-6-p by phosphoglucomutase. ; h,0h ch,0p0 phosphogiucomutase re opo h oh a@-d-glucose }-phosphate a-d-glucose 6-phosphate in liver and kidneys, g-6-p is converted into free e y glucose + pi by g-6-phosphatase. v glucose 6-p so, liver can release glucose into blood to maintain bi leva, \\ glucose muscle lana a relatively constant level of blood glucose. in the muscles, g-6-p is retained and cannot be diffused out of cells due to absence of g-6-phosphatase, so muscles can utilize it to produce atp for itself. n.b.: * phosphorolytic cleavage of glycogen is more advantageous than hydrolytic cleavage because: 1. the released units from glycogenolysis by phosphorylase are g-6-p which will enter glycolysis in muscle without need to be phosphorylated at the expense of atp. 2. g-6-p inside the muscle cells cannot diffuse out of the cells, whereas glucose can. regulation of glycogenolysis: |. covalent modification by hormones :- norepinephrine and epinephrine (in liver and muscle) or glucagon (in liver only) activate glycogen phosphorylase, while insulin inhibits it. 126"
    },
    {
        "page": 129,
        "text": "chapter x. carbohydrate metabolism 11. allosteric regulation: 1. g-6-p and atp inhibit glycogen phosphorylase because their elevated levels indicate that the cell isnt in need for more energy and there is no need to breakdown glycogen. 2. amp stimulates glycogen phosphorylase in muscles. n.b. glycogen storage diseases: - von gierks disease is due to deficiency of glucose 6-phosphatase - mc ardie syndrome is due to deficiency of muscle phosphorylase metabolism of other sugars fructose metabolism fructose atp fructokinase adp fructose vepaspnats fructose 1-phosphate aldolase dihydroxyacetone glyceraldehyde + phosphate triose | atp kinase | agp isomerase glyceraldehyde _ 3-phosphate figure 69. metabolism of fructose"
    },
    {
        "page": 130,
        "text": "chapter x. carbohydrate metabolism ee sehital ced -agenase h aidose@reductase chioh i h30h c | dome | . es yn hc-oh 7 n c=o ! (2) nadphh* napdf* nad* nadhh* d- glucose d-sorh ito) d- fructose =o figure 70. synthesis of free fructose from glucose: (polyol pathway) metabolic inborn errors include mainly: 1- essential fructosuria: it is due to hereditary deficiency of the fructokinase enzyme. it is asymptomatic condition. 2- hereditary fructose intolerance: it is due to hereditary deficiency of the liver enzyme aldolase b. it is characterized by attacks of hypoglycemia which may lead to death. galactose metabolism the major dietary source of galactose is lactose obtained from milk and milk products. the digestion of lactose occurs by lactase enzyme (/- galactosidase) of intestinal mucosal cell membrane. some galactose can also be obtained by lysosomal degradation of complex cho such as glycoproteins and glycolipids, which are important membrane components as well as from the turnover of bodys own cells. like fructose, entry of galactose into cells is not insulin dependent. galactosemia: this is an inherited disease due to deficiency of the galactose 1- phosphate uridy! transferase (most commonly) also due to inherited defects in galactokinase, or 4-epimerase and characterized by mental retardation, dah on coa 4128 -"
    },
    {
        "page": 131,
        "text": "chapter x. carbohydrate metabolism galactose-1-phoshate uridyltransferase (galt) figure 71. metabolism of galactose 129"
    },
    {
        "page": 132,
        "text": "chapter x. carbohydrate metabolism"
    }
]